FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Vassilis Georgoulias

Research Profile

Procedures

Disorders

Chemicals & Drugs

Concepts & Ideas

Co-author Network

Publications

TOP 3
Nikolaos Kentepozidis; Athanasios Kotsakis; Pavlos Papakotoulas; George Samonis; A Soultati; Lambros Vamvakas; Z Zafiriou; Sofia Agelaki; Maria Agelidou; L Chelis; Charalambos Christophylakis; Vassilis Georgoulias
Docetaxel plus cisplatin and bevacizumab for untreated patients with advanced/metastatic non-squamous non-small-cell lung cancer: a multicenter phase II study of the Hellenic Oncology Research Group.
Emmanouil Kontopodis; Nikolaos Pantazopoulos; Maria Rovithi; Nikolaos Vardakis; Ioannis Varthalitis; Vassilis Georgoulias; Stylianos Giassas; Dora Hatzidaki; Nikolaos Kentepozidis; Sofia Agelaki
A phase II study of metronomic oral vinorelbine administered in the second line and beyond in non-small cell lung cancer (NSCLC): a phase II study of the Hellenic Oncology Research Group.
A Voutsina; Zafeiris Zafeiriou; Aristea Kalikaki; Dimitris Mavroudis; Michael Papadakis; Eva D Papadimitraki; Maria Tzardi; Vassilis Georgoulias
Combined analysis of KRAS and PIK3CA mutations, MET and PTEN expression in primary tumors and corresponding metastases in colorectal cancer.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Vassilis Georgoulias (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Nikolaos Kentepozidis; Athanasios Kotsakis; Pavlos Papakotoulas; George Samonis; A Soultati; Lambros Vamvakas; Z Zafiriou; Sofia Agelaki; Maria Agelidou; L Chelis; Charalambos Christophylakis; Vassilis Georgoulias
Docetaxel plus cisplatin and bevacizumab for untreated patients with advanced/metastatic non-squamous non-small-cell lung cancer: a multicenter phase II study of the Hellenic Oncology Research Group.
Cancer chemotherapy and pharmacology 2013;71(3):605-12.
2013: Emmanouil Kontopodis; Nikolaos Pantazopoulos; Maria Rovithi; Nikolaos Vardakis; Ioannis Varthalitis; Vassilis Georgoulias; Stylianos Giassas; Dora Hatzidaki; Nikolaos Kentepozidis; Sofia Agelaki
A phase II study of metronomic oral vinorelbine administered in the second line and beyond in non-small cell lung cancer (NSCLC): a phase II study of the Hellenic Oncology Research Group.
Journal of chemotherapy (Florence, Italy) 2013;25(1):49-55.
2013: A Voutsina; Zafeiris Zafeiriou; Aristea Kalikaki; Dimitris Mavroudis; Michael Papadakis; Eva D Papadimitraki; Maria Tzardi; Vassilis Georgoulias
Combined analysis of KRAS and PIK3CA mutations, MET and PTEN expression in primary tumors and corresponding metastases in colorectal cancer.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2013;26(2):302-13.
2013: Silvy Laporte; Jean-Pierre Pignon; Jean-Louis Pujol; Emmanuel Quinaux; Pierre Squifflet; Jean-Yves Douillard; Frank Fossella; Vassilis Georgoulias; Shinzohy Kudoh; Noémie Baroux; Marc Buyse
Prediction of survival benefits from progression-free survival benefits in advanced non-small-cell lung cancer: evidence from a meta-analysis of 2334 patients from 5 randomised trials.
BMJ open 2013;3(3):.
2012: Zacharenia Saridaki; Lambros Vamvakas; Nikolaos Vardakis; A Voutsina; Nikolaos Androulakis; Vassilis Georgoulias; Dora Hatzidaki; E Kabouraki; Kostas Kalbakis; Dimitris Mavroudis; John Souglakos
A triplet combination with irinotecan (CPT-11), oxaliplatin (LOHP), continuous infusion 5-fluorouracil and leucovorin (FOLFOXIRI) plus cetuximab as first-line treatment in KRAS wt, metastatic colorectal cancer: a pilot phase II trial.
British journal of cancer 2012;107(12):1932-7.
2012: Zoe Giannousi; Ioannis Gioulbasanis; Kostas Kalbakis; Dimitris Mavroudis; Athanasios G Pallis; Vassilis Papadopoulos; Danai Dalliani; Vassilis Georgoulias; Alexandros Xyrafas; Christos N Papandreou
Nutritional status, acute phase response and depression in metastatic lung cancer patients: correlations and association prognosis.
Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 2012;20(8):1823-9.
2012: N Karachaliou; E Kontopodis; Vassiliki Bozionelou; Vassilis Georgoulias; Antonia Kalykaki; E Papadimitraki; Konstantinos Syrigos; K Tryfonidis; Nikolaos Ziras; Dimitris Mavroudis
A multicenter phase II trial of docetaxel and capecitabine as salvage treatment in anthracycline- and taxane-pretreated patients with metastatic breast cancer.
Cancer chemotherapy and pharmacology 2012;70(1):169-76.
2012: Nikolaos Kentepozidis; Athanasios Kotsakis; N Pantazopoulos; E Papadimitraki; A Soultati; Nikolaos Vardakis; V Bozionellou; Stylianos Giassas; Antonia Kalykaki; Vassilis Georgoulias
Paclitaxel in combination with carboplatin as salvage treatment in patients with castration-resistant prostate cancer: a Hellenic oncology research group multicenter phase II study.
Cancer chemotherapy and pharmacology 2012;70(1):161-8.
2012: Giannis Mountzios; Evagelos Popis; Nikolaos Vardakis; Maria Agelidou; Christos Emmanouilidis; Dora Hatzidaki; Niki Karachaliou; Emmanouil Kontopodis; Athanasios Kotsakis; Vassilis Georgoulias
Paclitaxel plus bevacizumab in patients with chemoresistant relapsed small cell lung cancer as salvage treatment: a phase II multicenter study of the Hellenic Oncology Research Group.
Lung cancer (Amsterdam, Netherlands) 2012;77(1):146-50.
2012: Vassilis Georgoulias; Kostas Kalbakis; Galatea Kallergi; Sofia Agelaki; Stella Apostolaki; Vassiliki Bozionelou; Maria Perraki; A Xyrafas; Dimitris Mavroudis
Trastuzumab decreases the incidence of clinical relapses in patients with early breast cancer presenting chemotherapy-resistant CK-19mRNA-positive circulating tumor cells: results of a randomized phase II study.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2012;23(7):1744-50.
2012: Nikolaos Androulakis; Stella Apostolaki; Vassiliki Bozionelou; Kostas Kalbakis; Dimitris Mavroudis; Athanasios G Pallis; Maria Perraki; A Xyrafas; Sofia Agelaki; Vassilis Georgoulias
Clinical relevance of circulating CK-19mRNA-positive tumour cells before front-line treatment in patients with metastatic breast cancer.
British journal of cancer 2012;106(12):1917-25.
2012: N Karachaliou; Ch Kouroussis; Vassilis Georgoulias; Kostas Kalbakis; Pavlos Papakotoulas; E Poppis; K Tryfonidis; Nikolaos Vardakis; Dimitris Mavroudis
A multicenter phase II trial of docetaxel plus gemcitabine as salvage treatment in anthracycline- and taxane-pretreated patients with metastatic breast cancer.
Cancer chemotherapy and pharmacology 2012;69(5):1345-52.
2012: Chara Papadaki; Maria Sfakianaki; Efstathios Stathopoulos; Kostas Tryfonidis; Maria Trypaki; Vassilis Georgoulias; Georgios Ioannidis; Eleni Lagoudaki; Dimitris Mavroudis; John Souglakos
ERCC1 and BRAC1 mRNA expression levels in the primary tumor could predict the effectiveness of the second-line cisplatin-based chemotherapy in pretreated patients with metastatic non-small cell lung cancer.
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2012;7(4):663-71.
2012: Athanasios G Pallis; Pavlos Papakotoulas; Kostas Tryfonidis; Lambros Vamvakas; Nikolaos Vardakis; Alexandra Voutsina; Sofia Agelaki; Stylianos Giassas; Nikolaos Kentepozidis; Athanasios Kotsakis; Vassilis Georgoulias
A phase II trial of erlotinib as front-line treatment in clinically selected patients with non-small-cell lung cancer.
Clinical lung cancer 2012;13(2):129-35.
2012: Athanasios G Pallis; Vassilis Georgoulias
Is there a standard regimen for first-line treatment of advanced/metastatic Non-Small-Cell Lung Cancer? What has meta-analyses contributed to today's standard of care.
Lung cancer (Amsterdam, Netherlands) 2012;75(3):269-74.
2012: Athanasios Kotsakis; Nikolaos Vardakis; E-K Vetsika; D Aggouraki; Ch Christophyllakis; S Christou; P Cordopatis; Vassilis Georgoulias; Dora Hatzidaki; G Konsolakis; K Kosmatopoulos; Dimitris Mavroudis
Clinical outcome of patients with various advanced cancer types vaccinated with an optimized cryptic human telomerase reverse transcriptase (TERT) peptide: results of an expanded phase II study.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2012;23(2):442-9.
2012: Eleni-Kyriaki Vetsika; Jeanne Menez-Jamet; Elisavet Papadimitraki; Despoina Aggouraki; Soultana Christou; Vassilis Georgoulias; Georgios Konsolakis; Kostas Kosmatopoulos; Athanasios Kotsakis; Dimitris Mavroudis
Immunological responses in cancer patients after vaccination with the therapeutic telomerase-specific vaccine Vx-001.
Cancer immunology, immunotherapy : CII 2012;61(2):157-68.
2012: Ioannis Boukovinas; Constantine A Constantinides; Nikolaos Androulakis; Athanasios Karampeazis; Nikolaos Kentepozidis; Athanasios Kostakopoulos; Athanasios Kotsakis; Vassilis Markos; Dimitris Mavroudis; Pavlos Papakotoulas; Aristidis Polyzos; George Samonis; Nikolaos Vardakis; Nikolaos Ziras; Vassilis Georgoulias
Chemotherapy with gemcitabine, cisplatin, and docetaxel in the treatment for patients with muscle-invasive bladder cancer: a multicenter phase II study of the Hellenic Oncology Research Group (HORG).
Cancer chemotherapy and pharmacology 2012;69(2):351-6.
2012: John Souglakos; Lambros Vamvakas; S Xynogalos; Nikolaos Ziras; Ioannis Boukovinas; Ch Christophyllakis; Vassilis Georgoulias; Stylianos Kakolyris; Nikolaos Kentepozidis; Ch Kouroussis; P Makrantonakis; Aristidis Polyzos
Randomised phase-II trial of CAPIRI (capecitabine, irinotecan) plus bevacizumab vs FOLFIRI (folinic acid, 5-fluorouracil, irinotecan) plus bevacizumab as first-line treatment of patients with unresectable/metastatic colorectal cancer (mCRC).
British journal of cancer 2012;106(3):453-9.
2012: Diamantis P Kofteridis; Eirini Koutsounaki; Sofia Maraki; Eleni Mavrogeni; Dimitra Dimopoulou; Foteini N Economidou; Vassilis Georgoulias; Kostas Kalbakis; Antonios Valachis; George Samonis
Skin and soft tissue infections in patients with solid tumours.
TheScientificWorldJournal 2012;2012():804518.
2012: Ioannis Gioulbasanis; Kyriaki Kitikidou; Andrew N Margioris; Dimitris Mavroudis; Konstantinos Papadimitriou; Christos N Papandreou; Anna Patrikidou; Christos Tsatsanis; Panagiotis J Vlachostergios; Vassilis Georgoulias
Baseline plasma levels of interleukin-8 in stage IV non-small-cell lung cancer patients: relationship with nutritional status and prognosis.
Nutrition and cancer 2012;64(1):41-7.
2011: Ioannis Gioulbasanis; Dimitris Mavroudis; Christos N Papandreou; Panagiotis J Vlachostergios; Vickie Baracos; Panagiotis Georgoulias; Sunita Ghosh; Zoe Giannousi; Vassilis Georgoulias
Mini Nutritional Assessment (MNA) and biochemical markers of cachexia in metastatic lung cancer patients: interrelations and associations with prognosis.
Lung cancer (Amsterdam, Netherlands) 2011;74(3):516-20.
2011: Eleni-Kyriaki Vetsika; Marina-Eleni Mela; Elisavet Papadimitraki; Stefania Patramani; Despoina Aggouraki; Marina Alefantinou; Charalampos Christophyllakis; Soultana Christou; Vassilis Georgoulias; Ageliki Kaskara; Georgios Konsolakis; Kostas Kosmatopoulos; Athanasios Kotsakis; Dimitris Mavroudis
Sequential administration of the native TERT572 cryptic peptide enhances the immune response initiated by its optimized variant TERT(572Y) in cancer patients.
Journal of immunotherapy (Hagerstown, Md. : 1997) 2011;34(9):641-50.
2011: Athanasios G Pallis; Lambros Vamvakas; Nikolaos Vardakis; Vassiliki Bozionelou; Dora Hatzidaki; Antonia Kalykaki; A Karampeazis; Athanasios Kotsakis; Dimitris Mavroudis; Vassilis Georgoulias
Efficacy and treatment tolerance in older patients with NSCLC: a meta-analysis of five phase III randomized trials conducted by the Hellenic Oncology Research Group.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2011;22(11):2448-55.
2011: Maria Spiliotaki; Vassilis Georgoulias; Haris Markomanolaki; Dimitris Mavroudis; Marilena Mela; Sofia Agelaki
Targeting the insulin-like growth factor I receptor inhibits proliferation and VEGF production of non-small cell lung cancer cells and enhances paclitaxel-mediated anti-tumor effect.
Lung cancer (Amsterdam, Netherlands) 2011;73(2):158-65.
2011: Athanasios Kotsakis; Dimitris Mavroudis; Georgia Sfakiotaki; George Stathopoulos; Lambros Vamvakas; Nikolaos Vardakis; Sofia Agelaki; Antonia Kalykaki; Nikolaos Kentepozidis; Emmanouel Kontopodis; Vassilis Georgoulias
A dose-escalation study of pemetrexed and docetaxel in non-small-cell lung cancer.
Cancer chemotherapy and pharmacology 2011;68(2):415-22.
2011: Georgios Ioannidis; Vassilis Georgoulias; John Souglakos
How close are we to customizing chemotherapy in early non-small cell lung cancer?
Therapeutic advances in medical oncology 2011;3(4):185-205.
2011: Aristidis Polyzos; Emmanouel Saloustros; Nikolaos Vardakis; Vassiliki Bozionelou; Vassilis Georgoulias; Stylianos Giassas; Kostas Kalbakis; Antonia Kalykaki; Nikolaos Kentepozidis; Emmanouel Kontopodis; Dimitris Mavroudis
Salvage treatment in metastatic breast cancer with weekly paclitaxel and bevacizumab.
Cancer chemotherapy and pharmacology 2011;68(1):217-23.
2011: Nikos Xenidis; Nikolaos Ziras; Stylianos Giassas; Ioannis Gioulbasanis; Kostas Kalbakis; Emmanouel Kontopodis; George Samonis; Nikolaos Vardakis; Ioannis Varthalitis; Vassilis Georgoulias
Α multicenter phase II study of pegylated liposomal doxorubicin in combination with irinotecan as second-line treatment of patients with refractory small-cell lung cancer.
Cancer chemotherapy and pharmacology 2011;68(1):63-8.
2011: Athanasios G Pallis; Vassilis Chandrinos; Georgia Pavlakou; Nikos Xenidis; Ioannis Varthalitis; Nikolaos Vardakis; Lambros Vamvakas; Emmanouel Kontopodis; Maria Rovithi; Vassilis Georgoulias
A multicenter phase I trial of metronomic oral vinorelbine plus cisplatin in patients with NSCLC.
Cancer chemotherapy and pharmacology 2011;67(6):1239-45.
2011: Athanasios Karampeazis; Nikolaos Kentepozidis; Athanasios G Pallis; Lambros Vamvakas; Nikolaos Vardakis; Athina Agelidou; Kyriakos Chainis; Vassilis Chandrinos; Charalambos Christophyllakis; Vassilis Georgoulias
Docetaxel vs. vinorelbine in elderly patients with advanced non--small-cell lung cancer: a hellenic oncology research group randomized phase III study.
Clinical lung cancer 2011;12(3):155-60.
2011: Markos Daskalakis; Dimitris Mavroudis; Elias Sanidas; Stella Apostolaki; I Askoxylakis; Eelco de Bree; Vassilis Georgoulias; John Melissas
Assessment of the effect of surgery on the kinetics of circulating tumour cells in patients with operable breast cancer based on cytokeratin-19 mRNA detection.
European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology 2011;37(5):404-10.
2011: E Saloustros; Zacharenia Saridaki; Nikolaos Vardakis; Georgia Milaki; M Rovithi; Sofia Agelaki; Vassilis Georgoulias; Kostas Kalbakis; Antonia Kalykaki; Dimitris Mavroudis
Metronomic vinorelbine plus bevacizumab as salvage therapy for patients with metastatic breast cancer.
Journal of B.U.ON. : official journal of the Balkan Union of Oncology 2011;16(2):215-8.
2011: Emmanouil Saloustros; Kostas Tryfonidis; Vassilis Georgoulias
Prophylactic and therapeutic strategies in chemotherapy-induced neutropenia.
Expert opinion on pharmacotherapy 2011;12(6):851-63.
2011: Ioannis Gioulbasanis; Vickie E Baracos; Z Giannousi; A Xyrafas; L Martin; Vassilis Georgoulias; Dimitris Mavroudis
Baseline nutritional evaluation in metastatic lung cancer patients: Mini Nutritional Assessment versus weight loss history.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2011;22(4):835-41.
2011: Athanasios G Pallis; Kostas Syrigos; Athanasios Kotsakis; Niki Karachaliou; Aris Polyzos; Vassilis Chandrinos; Ioannis Varthalitis; Charalambos Christophyllakis; Alexandros Ardavanis; Lambros Vamvakas; Nikolaos Vardakis; Zacharenia Saridaki; George Samonis; Stylianos Giassas; Vassilis Georgoulias; Sofia Agelaki
Second-line paclitaxel/carboplatin versus vinorelbine/carboplatin in patients who have advanced non-small-cell lung cancer pretreated with non-platinum-based chemotherapy: a multicenter randomized phase II study.
Clinical lung cancer 2011;12(2):100-5.
2011: Konstantin Krasagakis; Maria Metaxari; Maria Zervou; Efstathios N Stathopoulos; Juergen Eberle; Jean Kanitakis; Vassilis Georgoulias; Sabine Krüger-Krasagakis; Nektarios Tavernarakis; Androniki Tosca
Identification of the M541L sequence variation of the transmembrane KIT domain in Merkel cell carcinoma.
Anticancer research 2011;31(3):807-11.
2011: Ourania Katopodis; Aristidis Polyzos; Nikolaos Kentepozidis; Stylianos Giassas; Maria Rovithi; Vasiliki Bozionelou; Kostas Kalbakis; Lambros Vamvakas; Dimitris Mavroudis; Vassilis Georgoulias
Second-line chemotherapy with capecitabine (Xeloda) and docetaxel (Taxotere) in previously treated, unresectable adenocarcinoma of pancreas: the final results of a phase II trial.
Cancer chemotherapy and pharmacology 2011;67(2):361-8.
2011: Chara Papadaki; E Tsaroucha; L Kaklamanis; E Lagoudaki; M Trypaki; K Tryfonidis; Dimitris Mavroudis; Efstathios N Stathopoulos; Vassilis Georgoulias; John Souglakos
Correlation of BRCA1, TXR1 and TSP1 mRNA expression with treatment outcome to docetaxel-based first-line chemotherapy in patients with advanced/metastatic non-small-cell lung cancer.
British journal of cancer 2011;104(2):316-23.
2011: Panagiotis J Vlachostergios; V E Baracos; Panagiotis Georgoulias; Vassilis Georgoulias; S Ghosh; I Gioulbasanis; K Kamposioras; E Maragouli; Christos N Papandreou
Baseline insulin-like growth factor-I plasma levels, systemic inflammation, weight loss and clinical outcome in metastatic non-small cell lung cancer patients.
Oncology 2011;81(2):113-8.
2011: Emmanouil Saloustros; Alexandros Xyrafas; Maria Perraki; Sofia Agelaki; Stella Apostolaki; Vassilis Georgoulias; Kostas Kalbakis; Galatea Kallergi; Antonia Kalykaki; Dimitris Mavroudis
Cytokeratin-19 mRNA-positive circulating tumor cells during follow-up of patients with operable breast cancer: prognostic relevance for late relapse.
Breast cancer research : BCR 2011;13(3):R60.
2011: Galatea Kallergi; Dimitris Mavroudis; Maria A Papadaki; Eleni Politaki; Vassilis Georgoulias; Sofia Agelaki
Epithelial to mesenchymal transition markers expressed in circulating tumour cells of early and metastatic breast cancer patients.
Breast cancer research : BCR 2011;13(3):R59.
2011: Zacharenia Saridaki; Maria Tzardi; Chara Papadaki; Maria Sfakianaki; Fraga Pega; Aristea Kalikaki; Eleftheria Tsakalaki; Maria Trypaki; Ippokratis Messaritakis; Efstathios N Stathopoulos; Dimitris Mavroudis; Vassilis Georgoulias; John Souglakos
Impact of KRAS, BRAF, PIK3CA mutations, PTEN, AREG, EREG expression and skin rash in ≥ 2 line cetuximab-based therapy of colorectal cancer patients.
PloS one 2011;6(1):e15980.
2011: Nikolaos Vardakis; Ippokratis Messaritakis; Chara Papadaki; Georgios Agoglossakis; Maria Sfakianaki; Zacharenia Saridaki; Stella Apostolaki; Ioannis Koutroubakis; Maria Perraki; Dora Hatzidaki; Dimitris Mavroudis; Vassilis Georgoulias; John Souglakos
Prognostic significance of the detection of peripheral blood CEACAM5mRNA-positive cells by real-time polymerase chain reaction in operable colorectal cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2011;17(1):165-73.
2010: Athanasios Kotsakis; Dora Hatzidaki; Lambros Vamvakas; Nikolaos Vardakis; Antonia Kalykaki; Vassiliki Bozionelou; Nikolaos Androulakis; Kostas Kalbakis; Zacharenia Saridaki; Vassilis Georgoulias; Sofia Agelaki
A retrospective analysis of non-platinum-based first- and second-line chemotherapy in patients with advanced non-small cell lung cancer.
Anticancer research 2010;30(10):4335-42.
2010: Athanasios Kotsakis; Vassilis Georgoulias
Targeting epidermal growth factor receptor in the treatment of non-small-cell lung cancer.
Expert opinion on pharmacotherapy 2010;11(14):2363-89.
2010: Lambros Vamvakas; A Athanasiadis; A Karampeazis; S Kakolyris; A Polyzos; Ch Kouroussis; N Ziras; Kostas Kalbakis; Vassilis Georgoulias; J Souglakos
Clinical outcome of elderly patients with metastatic colorectal cancer treated with FOLFOXIRI versus FOLFIRI: Subgroup analysis of a randomized phase III trial from the Hellenic Oncology Research Group (HORG).
Critical reviews in oncology/hematology 2010;76(1):61-70.
2010: Panagiotis A Vorkas; Nikoleta Poumpouridou; Sophia Agelaki; Christos Kroupis; Vassilis Georgoulias; Evi S Lianidou
PIK3CA hotspot mutation scanning by a novel and highly sensitive high-resolution small amplicon melting analysis method.
The Journal of molecular diagnostics : JMD 2010;12(5):697-704.
2010: N Karachaliou; E Saloustros; Lambros Vamvakas; Dimitris Mavroudis; Vassilis Georgoulias
Proteinuria and favourable clinical response in a patient receiving paclitaxel + bevacizumab for metastatic breast cancer.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2010;21(8):1729-30.
2010: Sophia Baka; Sofia Agelaki; Athanasios Kotsakis; Marinos Veslemes; Pavlos Papakotoulas; Maria Agelidou; Athina Agelidou; Emily Tsaroucha; Georgia Pavlakou; Aleka Gerogianni; Nikolaos Androulakis; Lambros Vamvakas; Kostas Kalbakis; Dimitris Mavroudis; Vassilis Georgoulias
Phase III study comparing sequential versus alternate administration of cisplatin-etoposide and topotecan as first-line treatment in small cell lung cancer.
Anticancer research 2010;30(7):3031-8.
2010: A Valachis; Nikolaos P Polyzos; N Alpha Patsopoulos; Vassilis Georgoulias; Dimitris Mavroudis; Davide Mauri
Bevacizumab in metastatic breast cancer: a meta-analysis of randomized controlled trials.
Breast cancer research and treatment 2010;122(1):1-7.
2010: Aristea Kalikaki; ANASTASIOS KOUTSOPOULOS; Dora Hatzidaki; Maria Trypaki; Emmanouel Kontopodis; Efstathios N Stathopoulos; Dimitris Mavroudis; Vassilis Georgoulias; A Voutsina
Clinical outcome of patients with non-small cell lung cancer receiving front-line chemotherapy according to EGFR and K-RAS mutation status.
Lung cancer (Amsterdam, Netherlands) 2010;69(1):110-5.
2010: Zacharenia Saridaki; D Papadatos-Pastos; Maria Tzardi; Dimitris Mavroudis; E Bairaktari; H Arvanity; Efstathios N Stathopoulos; Vassilis Georgoulias; John Souglakos
BRAF mutations, microsatellite instability status and cyclin D1 expression predict metastatic colorectal patients' outcome.
British journal of cancer 2010;102(12):1762-8.
2010: Nikos Xenidis; Athanasios Kotsakis; Antonia Kalykaki; Ch Christophyllakis; Stylianos Giassas; Nikolaos Kentepozidis; Aristidis Polyzos; L Chelis; Nikolaos Vardakis; Lambros Vamvakas; Vassilis Georgoulias; Stylianos Kakolyris
Etoposide plus cisplatin followed by concurrent chemo-radiotherapy and irinotecan plus cisplatin for patients with limited-stage small cell lung cancer: A multicenter phase II study.
Lung cancer (Amsterdam, Netherlands) 2010;68(3):450-4.
2010: Antonis Valachis; Davide Mauri; Nikolaos P Polyzos; Dimitris Mavroudis; Vassilis Georgoulias; Giovanni Casazza
Partial breast irradiation or whole breast radiotherapy for early breast cancer: a meta-analysis of randomized controlled trials.
The breast journal 2010;16(3):245-51.
2010: Antonis Valachis; Nikolaos P Polyzos; Vassilis Georgoulias; Dimitris Mavroudis; Davide Mauri
Lack of evidence for fracture prevention in early breast cancer bisphosphonate trials: a meta-analysis.
Gynecologic oncology 2010;117(1):139-45.
2010: Emmanouel Saloustros; Ioannis Zaganas; Michail Mavridis; Lambros Vamvakas; Andreas Plaitakis; Vassilis Georgoulias; Dimitris Mavroudis
Anti-CV2 associated cerebellar degeneration after complete response to chemoradiation of head and neck carcinoma.
Journal of neuro-oncology 2010;97(2):291-4.
2010: Zacharenia Saridaki; Vassilis Georgoulias; John Souglakos
Mechanisms of resistance to anti-EGFR monoclonal antibody treatment in metastatic colorectal cancer.
World journal of gastroenterology : WJG 2010;16(10):1177-87.
2010: Davide Mauri; Antonis Valachis; Nikolaos P Polyzos; Lamprini Tsali; Dimitris Mavroudis; Vassilis Georgoulias; Giovanni Casazza
Does adjuvant bisphosphonate in early breast cancer modify the natural course of the disease? A meta-analysis of randomized controlled trials.
Journal of the National Comprehensive Cancer Network : JNCCN 2010;8(3):279-86.
2010: Massimo Di Maio; Nicola Lama; Alessandro Morabito; Egbert F Smit; Vassilis Georgoulias; Koji Takeda; Elisabeth Quoix; Dora Hatzidaki; Floris M Wachters; Vittorio Gebbia; Chun-Ming Tsai; Carlos Camps; Wolfgang Schuette; Paolo Chiodini; Maria Carmela Piccirillo; Francesco Perrone; Ciro Gallo; Cesare Gridelli
Clinical assessment of patients with advanced non-small-cell lung cancer eligible for second-line chemotherapy: a prognostic score from individual data of nine randomised trials.
European journal of cancer (Oxford, England : 1990) 2010;46(4):735-43.
2010: Antonis Valachis; Davide Mauri; Nikolaos P Polyzos; Dimitris Mavroudis; Vassilis Georgoulias; Giovanni Casazza
Fulvestrant in the treatment of advanced breast cancer: a systematic review and meta-analysis of randomized controlled trials.
Critical reviews in oncology/hematology 2010;73(3):220-7.
2010: Panayiotis A Theodoropoulos; Hara Polioudaki; Sofia Agelaki; Galatea Kallergi; Zacharenia Saridaki; Dimitris Mavroudis; Vassilis Georgoulias
Circulating tumor cells with a putative stem cell phenotype in peripheral blood of patients with breast cancer.
Cancer letters 2010;288(1):99-106.
2010: Emmanouil Saloustros; Nikolaos Androulakis; Lambros Vamvakas; Dimitris Mavroudis; Vassilis Georgoulias
Favorable clinical course of patients experiencing bevacizumab-induced proteinuria.
Case reports in oncology 2010;3(3):368-71.
2010: Athanasios G Pallis; Sofia Agelaki; Athina Agelidou; Ioannis Varthalitis; Kostas Syrigos; Nikolaos Kentepozidis; Georgia Pavlakou; Athanasios Kotsakis; Emmanouel Kontopodis; Vassilis Georgoulias
A randomized phase III study of the docetaxel/carboplatin combination versus docetaxel single-agent as second line treatment for patients with advanced/metastatic non-small cell lung cancer.
BMC cancer 2010;10():633.
2010: Niki Karachaliou; Aristidis Polyzos; Nikolaos Kentepozidis; Stylianos Kakolyris; Nikolaos Ziras; Nikolaos Vardakis; Antonia Kalykaki; Georgia Milaki; Vassilis Georgoulias; Nikolaos Androulakis
A multicenter phase II trial with irinotecan plus oxaliplatin as first-line treatment for inoperable/metastatic cancer of the biliary tract.
Oncology 2010;78(5-6):356-60.
2010: Sofia Agelaki; Dora Hatzidaki; Athanasios Kotsakis; Pavlos Papakotoulas; Aristidis Polyzos; Nikolaos Ziras; Ioannis Gioulbasanis; Athanasios Karampeazis; Athina Agelidou; Xanthi Tsiafaki; Vassilis Chandrinos; Maria Lerikou; Vassilis Georgoulias
Non-platinum-based first-line followed by platinum-based second-line chemotherapy or the reverse sequence in patients with advanced non-small cell lung cancer: a retrospective analysis by the lung cancer group of the Hellenic Oncology Research Group.
Oncology 2010;78(3-4):229-36.
2010: Dimitris Mavroudis; Pavlos Papakotoulas; Alexandros Ardavanis; Konstantinos Syrigos; Stylianos Kakolyris; Nikolaos Ziras; Charalambos Kouroussis; N Malamos; Aristidis Polyzos; C Christophyllakis; Nikolaos Kentepozidis; Vassilis Georgoulias
Randomized phase III trial comparing docetaxel plus epirubicin versus docetaxel plus capecitabine as first-line treatment in women with advanced breast cancer.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2010;21(1):48-54.
2010: Aristides Polyzos; Nikolaos Malamos; Ioannis Boukovinas; Adamos Adamou; Nikolaos Ziras; Kostas Kalbakis; Stylianos Kakolyris; Kostas Syrigos; Pavlos Papakotoulas; Charalambos Kouroussis; Nikolaos Karvounis; Lambros Vamvakas; Charalambos Christophyllakis; Athanasios Athanasiadis; Ioannis Varthalitis; Vassilis Georgoulias; Dimitris Mavroudis
FEC versus sequential docetaxel followed by epirubicin/cyclophosphamide as adjuvant chemotherapy in women with axillary node-positive early breast cancer: a randomized study of the Hellenic Oncology Research Group (HORG).
Breast cancer research and treatment 2010;119(1):95-104.
2010: Zoe Giannousi; Irene Manaras; Vassilis Georgoulias; George Samonis
Illness perceptions in Greek patients with cancer: a validation of the Revised-Illness Perception Questionnaire.
Psycho-oncology 2010;19(1):85-92.
2009: Magdalini Kioulafa; Ioanna Balkouranidou; Georgia Sotiropoulou; Loukas Kaklamanis; Dimitris Mavroudis; Vassilis Georgoulias; Evi S Lianidou
Methylation of cystatin M promoter is associated with unfavorable prognosis in operable breast cancer.
International journal of cancer. Journal international du cancer 2009;125(12):2887-92.
2009: Zacharenia Saridaki; Periklis Pappas; John Souglakos; Martha Nikolaidou; Nikolaos Vardakis; Athanasios Kotsakis; Marios Marselos; Vassilis Georgoulias; Dimitris Mavroudis
A dose escalation and pharmacokinetic study of the biweekly administration of paclitaxel, gemcitabine and oxaliplatin in patients with advanced solid tumors.
Cancer chemotherapy and pharmacology 2009;65(1):121-8.
2009: Stella Apostolaki; Maria Perraki; Galatea Kallergi; Maria Kafousi; Savvas Papadopoulos; Athanasios Kotsakis; Athanasios G Pallis; Nikos Xenidis; Lyda Kalmanti; Kostas Kalbakis; Sofia Agelaki; Antonia Kalykaki; Christos Stournaras; Efstathios N Stathopoulos; Vassilis Georgoulias; Dimitris Mavroudis
Detection of occult HER2 mRNA-positive tumor cells in the peripheral blood of patients with operable breast cancer: evaluation of their prognostic relevance.
Breast cancer research and treatment 2009;117(3):525-34.
2009: Vassiliki Bozionelou; Kostas Kalbakis; Lambros Vamvakas; Sofia Agelaki; Nikolaos Androulakis; Antonia Kalykaki; Vassilis Georgoulias; Dimitris Mavroudis
A phase I trial of gemcitabine, docetaxel and carboplatin administered every 2 weeks as first line treatment in patients with advanced breast cancer.
Cancer chemotherapy and pharmacology 2009;64(4):785-91.
2009: A Daskalaki; S Agelaki; M Perraki; S Apostolaki; N Xenidis; Efstathios N Stathopoulos; E Kontopodis; D Hatzidaki; D Mavroudis; Vassilis Georgoulias
Detection of cytokeratin-19 mRNA-positive cells in the peripheral blood and bone marrow of patients with operable breast cancer.
British journal of cancer 2009;101(4):589-97.
2009: John Souglakos; J Philips; R Wang; S Marwah; M Silver; M Tzardi; J Silver; S Ogino; S Hooshmand; E Kwak; E Freed; J A Meyerhardt; Z Saridaki; Vassilis Georgoulias; D Finkelstein; C S Fuchs; M H Kulke; R A Shivdasani
Prognostic and predictive value of common mutations for treatment response and survival in patients with metastatic colorectal cancer.
British journal of cancer 2009;101(3):465-72.
2009: Sophia Agelaki; Maria Spiliotaki; Harris Markomanolaki; Galatea Kallergi; Dimitris Mavroudis; Vassilis Georgoulias; Christos Stournaras
Caveolin-1 regulates EGFR signaling in MCF-7 breast cancer cells and enhances gefitinib-induced tumor cell inhibition.
Cancer biology & therapy 2009;8(15):1470-7.
2009: Athanasios G Pallis; Athina Agelidou; Sofia Agelaki; Ioannis Varthalitis; Georgia Pavlakou; Aleka Gerogianni; Pavlos Papakotoulas; Ageliki Rapti; Vassilis Chandrinos; Charalampos Christophyllakis; Vassilis Georgoulias
A multicenter randomized phase II study of the irinotecan/gemcitabine doublet versus irinotecan monotherapy in previously treated patients with extensive stage small-cell lung cancer.
Lung cancer (Amsterdam, Netherlands) 2009;65(2):187-91.
2009: Magdalini Kioulafa; Loukas Kaklamanis; Dimitris Mavroudis; Vassilis Georgoulias; Evi S Lianidou
Prognostic significance of RASSF1A promoter methylation in operable breast cancer.
Clinical biochemistry 2009;42(10-11):970-5.
2009: Chara Papadaki; Dimitris Mavroudis; Maria Trypaki; ANASTASIOS KOUTSOPOULOS; Efstathios N Stathopoulos; Dora Hatzidaki; Eleftheria Tsakalaki; Vassilis Georgoulias; John Souglakos
Tumoral expression of TXR1 and TSP1 predicts overall survival of patients with lung adenocarcinoma treated with first-line docetaxel-gemcitabine regimen.
Clinical cancer research : an official journal of the American Association for Cancer Research 2009;15(11):3827-33.
2009: M Kioulafa; Loukas Kaklamanis; Efstathios N Stathopoulos; Dimitris Mavroudis; Vassilis Georgoulias; Evi S Lianidou
Kallikrein 10 (KLK10) methylation as a novel prognostic biomarker in early breast cancer.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2009;20(6):1020-5.
2009: Lambros Vamvakas; Emmanouel Saloustros; Athanasios Karampeazis; Vassilis Georgoulias
Advanced non-small-cell lung cancer in the elderly.
Clinical lung cancer 2009;10(3):158-67.
2009: Nikos Xenidis; Michail Ignatiadis; Stella Apostolaki; Maria Perraki; Kostas Kalbakis; Sofia Agelaki; Efstathios N Stathopoulos; Grigorios Chlouverakis; Evi S Lianidou; Stylianos Kakolyris; Vassilis Georgoulias; Dimitris Mavroudis
Cytokeratin-19 mRNA-positive circulating tumor cells after adjuvant chemotherapy in patients with early breast cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2009;27(13):2177-84.
2009: Massimo Di Maio; Paolo Chiodini; Vassilis Georgoulias; Dora Hatzidaki; Koji Takeda; Floris M Wachters; Vittorio Gebbia; Egbert F Smit; Alessandro Morabito; Ciro Gallo; Francesco Perrone; Cesare Gridelli
Meta-analysis of single-agent chemotherapy compared with combination chemotherapy as second-line treatment of advanced non-small-cell lung cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2009;27(11):1836-43.
2009: Aristea Kalikaki; Maria Kanaki; Helen Vassalou; John Souglakos; A Voutsina; Vassilis Georgoulias; Dimitris Mavroudis
DNA repair gene polymorphisms predict favorable clinical outcome in advanced non-small-cell lung cancer.
Clinical lung cancer 2009;10(2):118-23.
2009: Galatea Kallergi; Harris Markomanolaki; Vicky Giannoukaraki; Maria A Papadaki; Areti Strati; Evi S Lianidou; Vassilis Georgoulias; Dimitris Mavroudis; Sofia Agelaki
Hypoxia-inducible factor-1alpha and vascular endothelial growth factor expression in circulating tumor cells of breast cancer patients.
Breast cancer research : BCR 2009;11(6):R84.
2009: Charalambos Kouroussis; Lambros Vamvakas; Nikolaos Vardakis; Athanasios Kotsakis; Antonia Kalykaki; Kostas Kalbakis; Zacharenia Saridaki; Nikolaos Kentepozidis; Stylianos Giassas; Vassilis Georgoulias
Continuous administration of daily low-dose temozolomide in pretreated patients with advanced non-small cell lung cancer: a phase II study.
Oncology 2009;76(2):112-7.
2008: Michail Ignatiadis; Vassilis Georgoulias; Dimitris Mavroudis
Micrometastatic disease in breast cancer: clinical implications.
European journal of cancer (Oxford, England : 1990) 2008;44(18):2726-36.
2008: Emmanouel Saloustros; Dimitris Mavroudis; Vassilis Georgoulias
Paclitaxel and docetaxel in the treatment of breast cancer.
Expert opinion on pharmacotherapy 2008;9(15):2603-16.
2008: Athina Markou; Emily G Tsaroucha; Loukas Kaklamanis; Marianthi Fotinou; Vassilis Georgoulias; Evi S Lianidou
Prognostic value of mature microRNA-21 and microRNA-205 overexpression in non-small cell lung cancer by quantitative real-time RT-PCR.
Clinical chemistry 2008;54(10):1696-704.
2008: A Kalikaki; ANASTASIOS KOUTSOPOULOS; M Trypaki; John Souglakos; Efstathios N Stathopoulos; Vassilis Georgoulias; Dimitris Mavroudis; A Voutsina
Comparison of EGFR and K-RAS gene status between primary tumours and corresponding metastases in NSCLC.
British journal of cancer 2008;99(6):923-9.
2008: Ioannis Gioulbasanis; Zacharenia Saridaki; Antonia Kalykaki; Lambros Vamvakas; Kostas Kalbakis; Michail Ignatiadis; Kyriakos Amarantidis; Stylianos Kakolyris; Vassilis Georgoulias; Dimitris Mavroudis
Gefitinib in combination with gemcitabine and vinorelbine in patients with metastatic breast cancer pre-treated with taxane and anthracycline chemotherapy: a phase I/II trial.
Anticancer research 2008;28(5B):3019-25.
2008: Emmanouel Saloustros; Vassilis Georgoulias
Docetaxel in the treatment of advanced non-small-cell lung cancer.
Expert review of anticancer therapy 2008;8(8):1207-22.
2008: Kostas Kalbakis; Periklis Pappas; Charalambos Kouroussis; Lambros Vamvakas; Antonia Kalykaki; Nikolaos Vardakis; Martha Nikolaidou; Marios Marselos; Vassilis Georgoulias; Dimitris Mavroudis
A dose escalation and pharmacokinetic study of biweekly pegylated liposomal doxorubicin, paclitaxel and oxaliplatin in patients with advanced solid tumors.
Cancer chemotherapy and pharmacology 2008;62(3):449-56.
2008: John Souglakos; I Boukovinas; M Taron; Pedro Méndez; Dimitris Mavroudis; M Tripaki; Dora Hatzidaki; ANASTASIOS KOUTSOPOULOS; Efstathios N Stathopoulos; Vassilis Georgoulias; R Rosell
Ribonucleotide reductase subunits M1 and M2 mRNA expression levels and clinical outcome of lung adenocarcinoma patients treated with docetaxel/gemcitabine.
British journal of cancer 2008;98(10):1710-5.
2008: Michail Ignatiadis; Galatea Kallergi; Maria Ntoulia; Maria Perraki; Stella Apostolaki; Maria Kafousi; Grigorios Chlouverakis; efstathios stathopoulos; Evi Lianidou; Vassilis Georgoulias; Dimitris Mavroudis
Prognostic value of the molecular detection of circulating tumor cells using a multimarker reverse transcription-PCR assay for cytokeratin 19, mammaglobin A, and HER2 in early breast cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2008;14(9):2593-600.
2008: Athanasios G Pallis; Aris Polyzos; Ioannis Boukovinas; Athina Agelidou; Lambros Lamvakas; Xanthi Tsiafaki; Maria Agelidou; Georgia Pavlakou; Vassilis Chandrinos; Stylianos Kakolyris; Charalambos Christophyllakis; Nikolaos Kentepozidis; Stelios Giassas; Nikolaos Androulakis; Sophia Agelaki; Vassilis Georgoulias
Pooled analysis of elderly patients with non-small cell lung cancer treated with front line docetaxel/gemcitabine regimen: the Hellenic Oncology Research Group experience.
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2008;3(5):505-10.
2008: George P Stathopoulos; Nikos Androulakis; John Souglakos; John G Stathopoulos; Vassilis Georgoulias
Present treatment and future expectations in advanced pancreatic cancer.
Anticancer research 2008;28(2B):1303-8.
2008: Michail Ignatiadis; Vassilis Georgoulias; Dimitris Mavroudis
Circulating tumor cells in breast cancer.
Current opinion in obstetrics & gynecology 2008;20(1):55-60.
2008: Ioannis Boukovinas; Chara Papadaki; Pedro Méndez; Miquel Taron; Dimitris Mavroudis; ANASTASIOS KOUTSOPOULOS; Maria Sanchez-Ronco; Jose Javier Sanchez; Maria Trypaki; Eustathios Staphopoulos; Vassilis Georgoulias; Rafael Rosell; John Souglakos
Tumor BRCA1, RRM1 and RRM2 mRNA expression levels and clinical response to first-line gemcitabine plus docetaxel in non-small-cell lung cancer patients.
PloS one 2008;3(11):e3695.
2008: Galatea Kallergi; Sofia Agelaki; Antonia Kalykaki; Christos Stournaras; Dimitris Mavroudis; Vassilis Georgoulias
Phosphorylated EGFR and PI3K/Akt signaling kinases are expressed in circulating tumor cells of breast cancer patients.
Breast cancer research : BCR 2008;10(5):R80.
2008: Stylianos Kakolyris; John Souglakos; Aristidis Polyzos; Alexandros Ardavanis; Nikolaos Ziras; Athanasios Athanasiadis; I Varthalitis; Kyriakos Amarantidis; S Tsousis; Lambros Vamvakas; Nikolaos Vardakis; Vassilis Georgoulias
Modified CAPOX (capecitabine plus oxaliplatin) regimen every two weeks as second-line treatment in patients with advanced colorectal cancer previously treated with irinotecan-based frontline therapy: a multicenter phase II study.
Oncology 2008;74(1-2):31-6.
2008: Antonia Kalykaki; Pavlos Papakotoulas; Sofoklis Tsousis; Ioannis Boukovinas; Kostas Kalbakis; Lambros Vamvakas; Athanasios Kotsakis; Nikolaos Vardakis; Persefoni Papadopoulou; Vassilis Georgoulias; Dimitris Mavroudis
Gemcitabine plus oxaliplatin (GEMOX) in pretreated patients with advanced ovarian cancer: a multicenter phase II study of the Hellenic Oncology Research Group (HORG).
Anticancer research 2008;28(1B):495-500.
2008: Vassilis Georgoulias; Nikolaos Androulakis; Athanasios Kotsakis; Dora Hatzidaki; Konstantinos Syrigos; Aristidis Polyzos; Athina Agelidou; Ioannis Varthalitis; Nikolaos Ziras; Maria Agelidou; Vassilis Chandrinos; Ioannis Boukovinas; A Geroyianni; Lambros Vamvakas; Dimitris Mavroudis
Docetaxel versus docetaxel plus gemcitabine as front-line treatment of patients with advanced non-small cell lung cancer: a randomized, multicenter phase III trial.
Lung cancer (Amsterdam, Netherlands) 2008;59(1):57-63.
2007: Athanasios G Pallis; A Voutsina; Antonia Kalikaki; John Souglakos; E Briasoulis; S Murray; ANASTASIOS KOUTSOPOULOS; M Tripaki; efstathios stathopoulos; D Mavroudis; Vassilis Georgoulias
'Classical' but not 'other' mutations of EGFR kinase domain are associated with clinical outcome in gefitinib-treated patients with non-small cell lung cancer.
British journal of cancer 2007;97(11):1560-6.
2007: Michail Ignatiadis; Maria Perraki; Stella Apostolaki; Eleni Politaki; Nikos Xenidis; Maria Kafousi; Efstathios N Stathopoulos; Evi S Lianidou; C Sotiriou; Vassilis Georgoulias; Dimitris Mavroudis
Molecular detection and prognostic value of circulating cytokeratin-19 messenger RNA-positive and HER2 messenger RNA-positive cells in the peripheral blood of women with early-stage breast cancer.
Clinical breast cancer 2007;7(11):883-9.
2007: Michail Ignatiadis; Nikos Xenidis; Maria Perraki; Stella Apostolaki; Eleni Politaki; Maria Kafousi; Efstathios N Stathopoulos; Aliki Stathopoulou; Evi S Lianidou; Grigorios Chlouverakis; C Sotiriou; Vassilis Georgoulias; Dimitris Mavroudis
Different prognostic value of cytokeratin-19 mRNA positive circulating tumor cells according to estrogen receptor and HER2 status in early-stage breast cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2007;25(33):5194-202.
2007: Nikos Maniadakis; Vassilis Fragoulakis; Athanasios G Pallis; P Prezerakos; Vassilis Georgoulias
Economic evaluation of docetaxel/gemcitabine versus docetaxel as frontline treatment of patients with advanced/metastatic non-small cell lung cancer in Greece.
Lung cancer (Amsterdam, Netherlands) 2007;58(2):275-81.
2007: Jean-Yves Douillard; Silvy Laporte; Frank Fossella; Vassilis Georgoulias; Jean-Louis Pujol; Kaoru Kubota; Alain Monnier; Shinzoh Kudoh; Jaime Ernesto Rubio; Michel Cucherat
Comparison of docetaxel- and vinca alkaloid-based chemotherapy in the first-line treatment of advanced non-small cell lung cancer: a meta-analysis of seven randomized clinical trials.
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2007;2(10):939-46.
2007: Nikos Xenidis; V Markos; Stella Apostolaki; Maria Perraki; Athanasios G Pallis; Georgia Sfakiotaki; Dionysios Papadatos-Pastos; L Kalmanti; Maria Kafousi; Efstathios N Stathopoulos; Stylianos Kakolyris; Dimitris Mavroudis; Vassilis Georgoulias
Clinical relevance of circulating CK-19 mRNA-positive cells detected during the adjuvant tamoxifen treatment in patients with early breast cancer.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2007;18(10):1623-31.
2007: Bernard Nordlinger; Eric Van Cutsem; Philippe Rougier; Claus-Henning Köhne; Marc Ychou; Alberto Sobrero; Rene Adam; Dag Arvidsson; Alfredo Carrato; Vassilis Georgoulias; FELICE GIULIANTE; Bengt Glimelius; Markus Golling; Thomas Gruenberger; Josep Tabernero; Harpreet Wasan; Graeme Poston
Does chemotherapy prior to liver resection increase the potential for cure in patients with metastatic colorectal cancer? A report from the European Colorectal Metastases Treatment Group.
European journal of cancer (Oxford, England : 1990) 2007;43(14):2037-45.
2007: Nikos Maniadakis; Athanasios G Pallis; Vassilis Fragoulakis; P Prezerakos; Vassilis Georgoulias
Economic analysis of a multicentre, randomised, phase III trial comparing FOLFOXIRI with FOLFIRI in patients with metastatic colorectal cancer in Greece.
Current medical research and opinion 2007;23(9):2251-7.
2007: ANASTASIOS KOUTSOPOULOS; Dimitris Mavroudis; Konstantina I Dambaki; John Souglakos; Eleni G Tzortzaki; John Drositis; George S Delides; Vassilis Georgoulias; Efstathios N Stathopoulos
Simultaneous expression of c-erbB-1, c-erbB-2, c-erbB-3 and c-erbB-4 receptors in non-small-cell lung carcinomas: correlation with clinical outcome.
Lung cancer (Amsterdam, Netherlands) 2007;57(2):193-200.
2007: Vassiliki Bozionelou; Lambros Vamvakas; Periklis Pappas; Sofia Agelaki; Nikolaos Androulakis; Antonia Kalykaki; Martha Nikolaidou; Nikolaos Kentepozidis; Stylianos Giassas; Marios Marselos; Vassilis Georgoulias; Dimitris Mavroudis
A dose escalation and pharmacokinetic study of biweekly pegylated liposomal doxorubicin, paclitaxel and gemcitabine in patients with advanced solid tumours.
British journal of cancer 2007;97(1):43-9.
2007: Irene Bolonaki; Athanasios Kotsakis; Elsa Papadimitraki; Despoina Aggouraki; George Konsolakis; Aphrodite Vagia; Charalambos Christophylakis; Irini Nikoloudi; Elefterios Magganas; Athanassios S Galanis; Paul Cordopatis; Kostas Kosmatopoulos; Vassilis Georgoulias; Dimitris Mavroudis
Vaccination of patients with advanced non-small-cell lung cancer with an optimized cryptic human telomerase reverse transcriptase peptide.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2007;25(19):2727-34.
2007: Stella Apostolaki; Maria Perraki; Athanasios G Pallis; Vassiliki Bozionelou; Sofia Agelaki; P Kanellou; Athanasios Kotsakis; E Politaki; Kostas Kalbakis; Antonia Kalykaki; Lambros Vamvakas; Vassilis Georgoulias; Dimitris Mavroudis
Circulating HER2 mRNA-positive cells in the peripheral blood of patients with stage I and II breast cancer after the administration of adjuvant chemotherapy: evaluation of their clinical relevance.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2007;18(5):851-8.
2007: I Gkioulbasanis; John Souglakos; Nikolaos Vardakis; Athanasios Kotsakis; Zacharenia Saridaki; Nikolaos Kentepozidis; Aristidis Polyzos; Stylianos Giassas; Michail Ignatiadis; Vassiliki Bozionelou; Charalambos Christophylakis; Vassilis Georgoulias
Dose escalating clinical study of high dose infusional 5-fluorouracil and leukovorin (AIO regimen) plus alternate weekly administration of oxaliplatin and irinotecan in patients with advanced tumors of the gastrointestinal tract.
Journal of B.U.ON. : official journal of the Balkan Union of Oncology 2007;12(2):197-202.
2007: John Michalakis; Spyros D Georgatos; Eelco de Bree; Hara Polioudaki; John Romanos; Vassilis Georgoulias; Dimitris D Tsiftsis; Panayiotis A Theodoropoulos
Short-term exposure of cancer cells to micromolar doses of paclitaxel, with or without hyperthermia, induces long-term inhibition of cell proliferation and cell death in vitro.
Annals of surgical oncology 2007;14(3):1220-8.
2007: John Souglakos; Antonia Kalykaki; Lambros Vamvakas; Nikolaos Androulakis; Kostas Kalbakis; Sofia Agelaki; Nikolaos Vardakis; M Tzardi; Athanasios Kotsakis; J Gioulbasanis; D Tsetis; Georgia Sfakiotaki; D Chatzidaki; Dimitris Mavroudis; Vassilis Georgoulias
Phase II trial of capecitabine and oxaliplatin (CAPOX) plus cetuximab in patients with metastatic colorectal cancer who progressed after oxaliplatin-based chemotherapy.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2007;18(2):305-10.
2007: Zacharenia Saridaki; Vassiliki Bozionelou; Nikolaos Kentepozidis; Athanasios Kotsakis; Nikolaos Vardakis; Antonia Kalykaki; Ioannis Gioulbasanis; Athanasios Karampeazis; Athanasios Karabeazis; Lambros Vamvakas; Vassilis Georgoulias; Dimitris Mavroudis
A dose escalation study of the biweekly administration of paclitaxel, oxaliplatin and capecitabine in patients with advanced solid tumors.
Oncology 2007;72(1-2):45-50.
2007: Galatea Kallergi; Sofia Agelaki; Harris Markomanolaki; Vassilis Georgoulias; Christos Stournaras
Activation of FAK/PI3K/Rac1 signaling controls actin reorganization and inhibits cell motility in human cancer cells.
Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology 2007;20(6):977-86.
2007: Christos Emmanouilides; Georgia Sfakiotaki; Nikolaos Androulakis; Kostas Kalbakis; Charalambos Christophylakis; Antonia Kalykaki; Lambros Vamvakas; Athanasios Kotsakis; Sofia Agelaki; Eleni Diamandidou; Nikolaos Touroutoglou; Adam Chatzidakis; Vassilis Georgoulias; Dimitris Mavroudis; John Souglakos
Front-line bevacizumab in combination with oxaliplatin, leucovorin and 5-fluorouracil (FOLFOX) in patients with metastatic colorectal cancer: a multicenter phase II study.
BMC cancer 2007;7():91.
2007: Galatea Kallergi; Dimitris Mavroudis; Vassilis Georgoulias; Christos Stournaras
Phosphorylation of FAK, PI-3K, and impaired actin organization in CK-positive micrometastatic breast cancer cells.
Molecular medicine (Cambridge, Mass.) 2007;13(1-2):79-88.
2007: John Souglakos; Nikolaos Vardakis; Nikolaos Androulakis; Stylianos Kakolyris; Charalabos Kourousis; Dimitris Mavroudis; Athanasios G Pallis; Sofia Agelaki; Kostas Kalbakis; Vassilis Georgoulias
Irinotecan plus weekly 5-fluorouracil and leucovorin as salvage treatment for patients with metastatic colorectal cancer: a phase II trial.
Digestive diseases (Basel, Switzerland) 2007;25(1):100-5.
2007: Athanasios G Pallis; Ch Christofillakis; Evangelos Tselepatiotis; Sofia Agelaki; Lambros Vamvakas; John Souglakos; Nikolaos Vardakis; Antonia Kalykaki; Athanasios Kotsakis; A Argiraki; Dimitris Mavroudis; Vassilis Georgoulias
Sequential administration of docetaxel followed by maintenance gefitinib, as salvage treatment in patients with advanced NSCLC: a multicenter phase II trial.
Lung cancer (Amsterdam, Netherlands) 2007;55(1):101-7.
2006: Stylianos Kakolyris; Nikolaos Ziras; Lambros Vamvakas; John Varthalitis; Pavlos Papakotoulas; Konstantinos Syrigos; Nikolaos Vardakis; Antonia Kalykaki; Kyriakos Amarantidis; Vassilis Georgoulias
Gemcitabine plus oxaliplatin combination (GEMOX regimen) in pretreated patients with advanced non-small cell lung cancer (NSCLC): a multicenter phase II study.
Lung cancer (Amsterdam, Netherlands) 2006;54(3):347-52.
2006: Alexandros Ardavanis; Dimitris Mavroudis; Kostas Kalbakis; Nikolaos Malamos; Konstantinos Syrigos; Lambros Vamvakas; Athanasios Kotsakis; Nikolaos Kentepozidis; Charalambos Kouroussis; Sofia Agelaki; Vassilis Georgoulias
Pegylated liposomal doxorubicin in combination with vinorelbine as salvage treatment in pretreated patients with advanced breast cancer: a multicentre phase II study.
Cancer chemotherapy and pharmacology 2006;58(6):742-8.
2006: Periklis Pappas; Dimitris Mavroudis; Martha Nikolaidou; Vassilis Georgoulias; Marios Marselos
Coadministration of oxaliplatin does not influence the pharmacokinetics of gemcitabine.
Anti-cancer drugs 2006;17(10):1185-91.
2006: Ioannis Boukovinas; Nikolaos Androulakis; Lambros Vamvakas; Pavlos Papakotoulas; Nikolaos Ziras; Aristidis Polyzos; Antonia Kalykaki; Athanasios Kotsakis; Nikos Xenidis; I Gioulmbasanis; Dimitris Mavroudis; Vassilis Georgoulias
Sequential gemcitabine and cisplatin followed by docetaxel as first-line treatment of advanced urothelial carcinoma: a multicenter phase II study of the Hellenic Oncology Research Group.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2006;17(11):1687-92.
2006: A Chan; M Martin; M Untch; M G Gil; Vicente Guillem Porta; M Wojtukiewicz; P Kellokumpu-Lehtinen; H L Sommer; Vassilis Georgoulias; N Battelli; Marek Pawlicki; D Aubert; T Bourlard; J Gasmi; G Villanova; Lubos Petruzelka
Vinorelbine plus trastuzumab combination as first-line therapy for HER 2-positive metastatic breast cancer patients: an international phase II trial.
British journal of cancer 2006;95(7):788-93.
2006: Sophia Koukouraki; Ludwig G. Strauss; Vassilis Georgoulias; Michael Eisenhut; Uwe Haberkorn; Antonia Dimitrakopoulou-Strauss
Comparison of the pharmacokinetics of 68Ga-DOTATOC and [18F]FDG in patients with metastatic neuroendocrine tumours scheduled for 90Y-DOTATOC therapy.
European journal of nuclear medicine and molecular imaging 2006;33(10):1115-22.
2006: Aliki Stathopoulou; Maria Ntoulia; Maria Perraki; Stella Apostolaki; Dimitris Mavroudis; Nikolaos Malamos; Vassilis Georgoulias; Evi S Lianidou
A highly specific real-time RT-PCR method for the quantitative determination of CK-19 mRNA positive cells in peripheral blood of patients with operable breast cancer.
International journal of cancer. Journal international du cancer 2006;119(7):1654-9.
2006: George P Stathopoulos; Konstantinos Syrigos; Gerasimos Aravantinos; Aristidis Polyzos; Pavlos Papakotoulas; G Fountzilas; Anna Potamianou; Nikolaos Ziras; John Boukovinas; John Varthalitis; Nikolaos Androulakis; Athanasios Kotsakis; George Samonis; Vassilis Georgoulias
A multicenter phase III trial comparing irinotecan-gemcitabine (IG) with gemcitabine (G) monotherapy as first-line treatment in patients with locally advanced or metastatic pancreatic cancer.
British journal of cancer 2006;95(5):587-92.
2006: Maria Ntoulia; Aliki Stathopoulou; Michail Ignatiadis; Nikolaos Malamos; Dimitris Mavroudis; Vassilis Georgoulias; Evi S Lianidou
Detection of Mammaglobin A-mRNA-positive circulating tumor cells in peripheral blood of patients with operable breast cancer with nested RT-PCR.
Clinical biochemistry 2006;39(9):879-87.
2006: Maria Ntoulia; Loukas Kaklamanis; Christos Valavanis; Maria Kafousi; Efstathios N Stathopoulos; Petroula Arapantoni; Dimitris Mavroudis; Vassilis Georgoulias; Evi S Lianidou
HER-2 DNA quantification of paraffin-embedded breast carcinomas with LightCycler real-time PCR in comparison to immunohistochemistry and chromogenic in situ hybridization.
Clinical biochemistry 2006;39(9):942-6.
2006: Nikos Xenidis; Maria Perraki; Maria Kafousi; Stella Apostolaki; Irene Bolonaki; Aliki Stathopoulou; Kostas Kalbakis; Nikolaos Androulakis; Charalambos Kouroussis; Thanos Pallis; Charalambos Christophylakis; Katerina Argyraki; Evi S Lianidou; Stathis Stathopoulos; Vassilis Georgoulias; Dimitris Mavroudis
Predictive and prognostic value of peripheral blood cytokeratin-19 mRNA-positive cells detected by real-time polymerase chain reaction in node-negative breast cancer patients.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2006;24(23):3756-62.
2006: Dora Hatzidaki; Sofia Agelaki; Dimitris Mavroudis; Ioannis Vlachonikolis; Athanasios Alegakis; Vassilis Georgoulias
A retrospective analysis of second-line chemotherapy or best supportive care in patients with advanced-stage non-small-cell lung cancer.
Clinical lung cancer 2006;8(1):49-55.
2006: P Makrantonakis; Panagiotis Ziotopoulos; Athina Agelidou; Aristidis Polyzos; A Ziras; Vassilis Chandrinos; Andreas Vossos; Antonia Kalykaki; Nikolaos Androulakis; A Geroyianni; Vassilis Georgoulias
Vinorelbine and cisplatin combination in pretreated patients with advanced non-small cell lung cancer pretreated with a taxane-based regimen: a multicenter phase II study.
Lung cancer (Amsterdam, Netherlands) 2006;53(1):85-90.
2006: Stylianos Kakolyris; Athina Agelidou; Nikolaos Androulakis; E Tsaroucha; Ch Kouroussis; Maria Agelidou; N Karvounis; Marinos Veslemes; Charalambos Christophylakis; A Argyraki; A Geroyianni; Vassilis Georgoulias
Cisplatin plus etoposide chemotherapy followed by thoracic irradiation and paclitaxel plus cisplatin consolidation therapy for patients with limited stage small cell lung carcinoma.
Lung cancer (Amsterdam, Netherlands) 2006;53(1):59-65.
2006: Antonia Dimitrakopoulou-Strauss; Vassilis Georgoulias; Michael Eisenhut; Felix Herth; Sophia Koukouraki; Helmut R Mäcke; Uwe Haberkorn; Ludwig G. Strauss
Quantitative assessment of SSTR2 expression in patients with non-small cell lung cancer using(68)Ga-DOTATOC PET and comparison with (18)F-FDG PET.
European journal of nuclear medicine and molecular imaging 2006;33(7):823-30.
2006: Athanasios G Pallis; Athina Agelidou; Pavlos Papakotoulas; Aimilia Tsaroucha; Maria Agelidou; Sofia Agelaki; Nikolaos Androulakis; Lambros Vamvakas; Athina Gerogianni; Athanasios Kotsakis; Nikolaos Kentepozidis; Vassilis Georgoulias
A multicenter phase II study of sequential vinorelbine and cisplatin followed by docetaxel and gemcitabine in patients with advanced non-small cell lung cancer.
Lung cancer (Amsterdam, Netherlands) 2006;52(2):165-71.
2006: Sophia Koukouraki; Ludwig G. Strauss; Vassilis Georgoulias; Jochen Schuhmacher; Uwe Haberkorn; Nikolaos Karkavitsas; Antonia Dimitrakopoulou-Strauss
Evaluation of the pharmacokinetics of 68Ga-DOTATOC in patients with metastatic neuroendocrine tumours scheduled for 90Y-DOTATOC therapy.
European journal of nuclear medicine and molecular imaging 2006;33(4):460-6.
2006: John Souglakos; Nikolaos Androulakis; Konstantinos Syrigos; Aristidis Polyzos; Nikolaos Ziras; Athanasios Athanasiadis; Stylianos Kakolyris; S Tsousis; Ch Kouroussis; Lambros Vamvakas; Antonia Kalykaki; George Samonis; Dimitris Mavroudis; Vassilis Georgoulias
FOLFOXIRI (folinic acid, 5-fluorouracil, oxaliplatin and irinotecan) vs FOLFIRI (folinic acid, 5-fluorouracil and irinotecan) as first-line treatment in metastatic colorectal cancer (MCC): a multicentre randomised phase III trial from the Hellenic Oncology Research Group (HORG).
British journal of cancer 2006;94(6):798-805.
2006: A Karampeazis; Lambros Vamvakas; Sofia Agelaki; Nikolaos Kentepozidis; E Papadimitraki; Ioannis Gioulbasanis; Nikolaos Vardakis; Michail Ignatiadis; Dimitris Mavroudis; Vassilis Georgoulias
A dose escalation study of biweekly oral vinorelbine and gemcitabine in patients with solid tumors.
Oncology 2006;71(5-6):347-53.
2006: Michail Ignatiadis; Aristidis Polyzos; George P Stathopoulos; Evangelos Tselepatiotis; Charalambos Christophylakis; Kostas Kalbakis; Lambros Vamvakas; Athanasios Kotsakis; Anna Potamianou; Vassilis Georgoulias
A multicenter phase II study of docetaxel in combination with gefitinib in gemcitabine-pretreated patients with advanced/metastatic pancreatic cancer.
Oncology 2006;71(3-4):159-63.
2006: Antonia Kalykaki; Lambros Vamvakas; Sofia Agelaki; Kostas Kalbakis; Nikolaos Vardakis; Georgia Sfakiotaki; Michail Ignatiadis; Zacharenia Saridaki; A Karampeazis; A Karabeazis; Dimitris Mavroudis; Vassilis Georgoulias
A dose escalation study of gemcitabine plus pemetrexed administered biweekly in patients with solid tumors.
Oncology 2006;71(3-4):197-203.
2006: Athanasios Kotsakis; Ch Kouroussis; Nikolaos Androulakis; Sofia Agelaki; Kostas Kalbakis; Lambros Vamvakas; Nikolaos Vardakis; Antonia Kalykaki; Aristidis Polyzos; Vassilis Georgoulias; Dimitris Mavroudis
A dose-escalation study of pegylated liposomal Doxorubicin and oxaliplatin in patients with advanced solid tumors.
Oncology 2006;71(3-4):190-6.
2006: Dimitris Mavroudis; I Bolonakis; Sébastien Cornet; G Myllaki; P Kanellou; Athanasios Kotsakis; Athanassios S Galanis; Irini Nikoloudi; M Spyropoulou; J Menez; Isabelle Miconnet; M Niniraki; Paul Cordopatis; Kostas Kosmatopoulos; Vassilis Georgoulias
A phase I study of the optimized cryptic peptide TERT(572y) in patients with advanced malignancies.
Oncology 2006;70(4):306-14.
2006: Nikolaos Androulakis; Gerasimos Aravantinos; Konstantinos Syrigos; Aristidis Polyzos; Nikolaos Ziras; Evangelos Tselepatiotis; George Samonis; Nikolaos Kentepozidis; Stylianos Giassas; Lambros Vamvakas; Vassilis Georgoulias
Oxaliplatin as first-line treatment in inoperable biliary tract carcinoma: a multicenter phase II study.
Oncology 2006;70(4):280-4.
2006: Stylianos Kakolyris; Kostas Kalbakis; Anna Potamianou; Nikolaos Malamos; Lambros Vamvakas; C Christophillakis; Evangelos Tselepatiotis; Stylianos Giassas; Dimitris Mavroudis; D Mavrousis; Kyriakos Amarantidis; Vassilis Georgoulias
Salvage chemotherapy with gemcitabine and oxaliplatin in heavily pretreated patients with metastatic breast cancer: a multicenter phase II study.
Oncology 2006;70(4):273-9.
2006: John Souglakos; Lambros Vamvakas; Stella Apostolaki; Maria Perraki; Zacharenia Saridaki; Irine Kazakou; Athanasios G Pallis; Charalambos Kouroussis; Nikolaos Androulakis; Kostas Kalbakis; Georgia Millaki; Dimitris Mavroudis; Vassilis Georgoulias
Central nervous system relapse in patients with breast cancer is associated with advanced stages, with the presence of circulating occult tumor cells and with the HER2/neu status.
Breast cancer research : BCR 2006;8(4):R36.
2006: Nikolaos Ziras; Anna Potamianou; I Varthalitis; Konstantinos Syrigos; S Tsousis; Ioannis Boukovinas; Evangelos Tselepatiotis; C Christofillakis; Vassilis Georgoulias
Multicenter phase II study of gemcitabine and oxaliplatin (GEMOX) as second-line chemotherapy in colorectal cancer patients pretreated with 5-fluorouracil plus irinotecan.
Oncology 2006;70(2):106-14.
2005: John Michalakis; Spyros D Georgatos; John Romanos; Helen Koutala; Vassilis Georgoulias; Dimitris D Tsiftsis; Panayiotis A Theodoropoulos
Micromolar taxol, with or without hyperthermia, induces mitotic catastrophe and cell necrosis in HeLa cells.
Cancer chemotherapy and pharmacology 2005;56(6):615-22.
2005: Michail Ignatiadis; Dimitris Mavroudis; Marinos Veslemes; John Boukovinas; Konstantinos Syrigos; Maria Agelidou; Athina Agelidou; Athina Gerogianni; Georgia Pavlakou; Evangelos Tselepatiotis; John Nikolakopoulos; Vassilis Georgoulias
Sequential versus alternating administration of cisplatin/etoposide and topotecan as first-line treatment in extensive-stage small-cell lung cancer: preliminary results of a Phase III Trial of the Hellenic Oncology Research Group.
Clinical lung cancer 2005;7(3):183-9.
2005: george chalkiadakis; Konstantinos G Lasithiotakis; Ioannis E Petrakis; Charalabos Kourousis; Vassilis Georgoulias
Major hepatectomy and right hemicolectomy at the time of primary cytoreductive surgery for advanced ovarian cancer: report of a case.
International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 2005;15(6):1115-9.
2005: Sofia Agelaki; Vassilis Georgoulias
Epidermal growth factor receptor inhibitors in the treatment of non-small cell lung cancer.
Expert opinion on emerging drugs 2005;10(4):855-74.
2005: Vassilis Georgoulias; Athina Agelidou; Konstantinos Syrigos; Ageliki Rapti; Maria Agelidou; J Nikolakopoulos; Aristidis Polyzos; Athanasios Athanasiadis; Evangelos Tselepatiotis; Nikolaos Androulakis; Kostas Kalbakis; George Samonis; Dimitris Mavroudis
Second-line treatment with irinotecan plus cisplatin vs cisplatin of patients with advanced non-small-cell lung cancer pretreated with taxanes and gemcitabine: a multicenter randomised phase II study.
British journal of cancer 2005;93(7):763-9.
2005: Panagiotis Ziotopoulos; Nikolaos Androulakis; Efthimia Mylonaki; Vassilis Chandrinos; Emmanouel Zachariadis; Ioannis Boukovinas; Athina Agelidou; Nikolaos Kentepozidis; Michail Ignatiadis; Andreas Vossos; Vassilis Georgoulias
Front-line treatment of advanced non-small cell lung cancer with irinotecan and docetaxel: a multicentre phase II study.
Lung cancer (Amsterdam, Netherlands) 2005;50(1):115-22.
2005: Aristidis Polyzos; Christos Kosmas; Helen Toufexi; Nikolaos Malamos; Antonios Lagadas; Christos Kosmidis; Panagiotis Ginopoulos; Nikolaos Ziras; Kostas Kandilis; Vassilis Georgoulias
Docetaxel in combination with irinotecan (CPT-11) in platinum-resistant paclitaxel-pretreated ovarian cancer.
Anticancer research 2005;25(5):3559-64.
2005: Ageliki Rapti; Athina Agelidou; Ioannis Stergiou; Maria Agelidou; Ioannis Nikolakopoulos; John Varthalitis; Antonia Kalykaki; Kyriakos Chainis; Nikolaos Tzanakis; Vassilis Georgoulias
Combination of vinorelbine plus gemcitabine in previously treated patients with small cell lung cancer: a multicentre phase II study.
Lung cancer (Amsterdam, Netherlands) 2005;49(2):241-4.
2005: Gerasimos Aravantinos; George Fountzilas; Paris A Kosmidis; Meletios A Dimopoulos; George P Stathopoulos; Nicholas Pavlidis; Dimitrios Bafaloukos; Christos Papadimitriou; S Karpathios; Vassilis Georgoulias; Pavlos Papakostas; Haralabos P Kalofonos; E Grimani; Dimosthenis V Skarlos
Paclitaxel plus carboplatin versus paclitaxel plus alternating carboplatin and cisplatin for initial treatment of advanced ovarian cancer: long-term efficacy results: a Hellenic Cooperative Oncology Group (HeCOG) study.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2005;16(7):1116-22.
2005: Chris Twelves; Alfred Wong; Marek P Nowacki; Markus Abt; Howard Burris; Alfredo Carrato; Jim Cassidy; Andrés Cervantes; Jan Fagerberg; Vassilis Georgoulias; Fares Husseini; Duncan I Jodrell; Piotr Koralewski; Hendrik Kröning; Jean Maroun; Norbert Marschner; Joseph McKendrick; Marek Pawlicki; Riccardo Rosso; Johannes Schüller; Jean-François Seitz; Borut Stabuc; Jerzy Tujakowski; Guy Van Hazel; Jerzy Zaluski; Werner Scheithauer
Capecitabine as adjuvant treatment for stage III colon cancer.
The New England journal of medicine 2005;352(26):2696-704.
2005: Vassilis Georgoulias; Alexandros Ardavanis; Xanthi Tsiafaki; Athina Agelidou; Penelope Mixalopoulou; Ourania Anagnostopoulou; Panagiotis Ziotopoulos; Michael Toubis; Konstantinos Syrigos; Nikolaos Samaras; Aristidis Polyzos; Anna Christou; Stylianos Kakolyris; Charalambos Kouroussis; Nikolaos Androulakis; George Samonis; Dora Chatzidaki
Vinorelbine plus cisplatin versus docetaxel plus gemcitabine in advanced non-small-cell lung cancer: a phase III randomized trial.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(13):2937-45.
2005: Aristidis Polyzos; Konstantinos Syrigos; John Stergiou; Christos Panopoulos; Anna Potamianou; Lambros Vamvakas; Vassilis Georgoulias
Phase I trial of weekly docetaxel with a 4-weekly cisplatin administration in patients with advanced gastric carcinoma.
Cancer chemotherapy and pharmacology 2005;55(5):466-70.
2005: Nikos Androulakis; Vassilis Georgoulias
NSCLC--platinum or not.
Lung cancer (Amsterdam, Netherlands) 2005;47(3):381-3.
2005: Efstathios N Stathopoulos; Elias Sanidas; Maria Kafousi; Dimitris Mavroudis; John Askoxylakis; Vassiliki Bozionelou; Maria Perraki; Dimitris D Tsiftsis; Vassilis Georgoulias
Detection of CK-19 mRNA-positive cells in the peripheral blood of breast cancer patients with histologically and immunohistochemically negative axillary lymph nodes.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2005;16(2):240-6.
2005: John Souglakos; Nikolaos Vardakis; Nikolaos Androulakis; Stylianos Kakolyris; Ch Kouroussis; Dimitris Mavroudis; Athanasios G Pallis; Sofia Agelaki; Kostas Kalbakis; Vassilis Georgoulias
Irinotecan plus weekly 5-fluorouracil and leucovorin as salvage treatment for patients with metastatic colorectal cancer: A phase II trial.
Journal of B.U.ON. : official journal of the Balkan Union of Oncology 2005;10(1):47-52.
2005: John Souglakos; Athanasios G Pallis; Stylianos Kakolyris; Dimitris Mavroudis; Nikolaos Androulakis; Charalambos Kouroussis; Sofia Agelaki; Nikos Xenidis; Georgia Milaki; Vassilis Georgoulias
Combination of irinotecan (CPT-11) plus 5-fluorouracil and leucovorin (FOLFIRI regimen) as first line treatment for elderly patients with metastatic colorectal cancer: a phase II trial.
Oncology 2005;69(5):384-90.
2005: Anna Potamianou; Nikolaos Androulakis; Pavlos Papakotoulas; Helen Toufexi; Christos Latoufis; Charalambos Kouroussis; Charalambos Christofilakis; Nikos Xenidis; Vassilis Georgoulias; Aristidis Polyzos
Sequential combination of paclitaxel-carboplatin and paclitaxel-liposomal doxorubicin as a first-line treatment in patients with ovarian cancer. A multicenter phase II trial.
Oncology 2005;69(4):348-53.
2005: John Souglakos; Stylianos Kakolyris; Nikolaos Vardakis; Nikolaos Androulakis; Dimitris Mavroudis; Lambros Vamvakas; Charalambos Kouroussis; Sofia Agelaki; Zacharenia Saridaki; Vassilis Georgoulias
A dose escalating study of oxaliplatin and high dose weekly leucovorin and 5-Fluorouracil in patients with advanced solid tumors.
Cancer investigation 2005;23(6):505-10.
2005: Ch Kouroussis; Nikolaos Androulakis; Lambros Vamvakas; Antonia Kalykaki; S Spiridonakou; Nikolaos Kentepozidis; Zacharenia Saridaki; El Xiropoulou; Vassilis Georgoulias
Phase I study of weekly docetaxel and liposomal doxorubicin in patients with advanced solid tumors.
Oncology 2005;69(3):202-7.
2005: Christos Lionis; George Samoutis; Charalambos Kouroussis; Maria Trigoni; Vassilis Georgoulias
Teaching cancer management to primary care health staff: the first experiences gained from Crete.
Journal of cancer education : the official journal of the American Association for Cancer Education 2005;20(1):6-7.
2004: Vassiliki Bozionellou; Dimitris Mavroudis; Maria Perraki; Savvas Papadopoulos; Stella Apostolaki; Efstathios N Stathopoulos; Aliki Stathopoulou; Evi S Lianidou; Vassilis Georgoulias
Trastuzumab administration can effectively target chemotherapy-resistant cytokeratin-19 messenger RNA-positive tumor cells in the peripheral blood and bone marrow of patients with breast cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2004;10(24):8185-94.
2004: Charalambos Kouroussis; Kostas Kalbakis; Nikolaos Androulakis; Sofia Agelaki; Lambros Vamvakas; Konstantinos Malas; John Souglakos; Nikolaos Vardakis; Vassilis Georgoulias
A dose escalation study of leucovorin (LV) and 48-hour continuous infusion of 5-fluorouracil in combination with cyclophosphamide and vinorelbine in pretreated patients with metastatic breast cancer.
Anticancer research 2004;24(6):4217-21.
2004: Vassilis Georgoulias; Charalambos Kouroussis; Athina Agelidou; Ioannis Boukovinas; P Palamidas; E Stavrinidis; Aristidis Polyzos; Konstantinos Syrigos; Marinos Veslemes; Michael Toubis; Alexandros Ardavanis; Evangelos Tselepatiotis; I Vlachonikolis
Irinotecan plus gemcitabine vs irinotecan for the second-line treatment of patients with advanced non-small-cell lung cancer pretreated with docetaxel and cisplatin: a multicentre, randomised, phase II study.
British journal of cancer 2004;91(3):482-8.
2004: John Souglakos; Konstantinos Syrigos; Anna Potamianou; Aristidis Polyzos; Ioannis Boukovinas; Nikolaos Androulakis; Ch Kouroussis; Nikolaos Vardakis; Ch Christophilakis; Athanasios Kotsakis; Vassilis Georgoulias
Combination of irinotecan (CPT-11) plus oxaliplatin (L-OHP) as first-line treatment in locally advanced or metastatic gastric cancer: a multicentre phase II trial.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2004;15(8):1204-9.
2004: Vassilis Georgoulias; Alexandros Ardavanis; Athina Agelidou; Maria Agelidou; Vassilis Chandrinos; Emilia Tsaroucha; Michael Toumbis; Charalambos Kouroussis; Konstantinos Syrigos; Aristidis Polyzos; Nikolaos Samaras; Pavlos Papakotoulas; Charalambos Christofilakis; Nikolaos Ziras; Athanasios Alegakis
Docetaxel versus docetaxel plus cisplatin as front-line treatment of patients with advanced non-small-cell lung cancer: a randomized, multicenter phase III trial.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2004;22(13):2602-9.
2004: Charalambos Kouroussis; Dimitris Mavroudis; Stylianos Kakolyris; Argyro Voloudaki; Kostas Kalbakis; John Souglakos; Sofia Agelaki; Konstantinos Malas; Vassiliki Bozionelou; Vassilis Georgoulias
High incidence of pulmonary toxicity of weekly docetaxel and gemcitabine in patients with non-small cell lung cancer: results of a dose-finding study.
Lung cancer (Amsterdam, Netherlands) 2004;44(3):363-8.
2004: Maria Anatoliotaki; V Valatas; Elpis Mantadakis; H Apostolakou; D Mavroudis; Vassilis Georgoulias; K V Rolston; Dimitrios P Kontoyiannis; Emmanouil Galanakis; George Samonis
Bloodstream infections in patients with solid tumors: associated factors, microbial spectrum and outcome.
Infection 2004;32(2):65-71.
2004: Sofia Agelaki; Marinos Veslemes; Konstantinos Syrigos; Filippos Palamidas; Aristidis Polyzos; Pavlos Papakotoulas; Nikolaos Kentepozidis; Georgia Milaki; Nikolaos Tzanakis; Charalambos Kouroussis; Lambros Vamvakas; Vassilis Georgoulias
A multicenter phase II study of the combination of gemcitabine and docetaxel in previously treated patients with small cell lung cancer.
Lung cancer (Amsterdam, Netherlands) 2004;43(3):329-33.
2004: Alexandra Giatromanolaki; Michael I Koukourakis; Stylianos Kakolyris; Dimitris Mavroudis; Charalambos Kouroussis; Chrysa Mavroudi; Maria Perraki; Efthimios Sivridis; Vassilis Georgoulias
Assessment of highly angiogenic and disseminated in the peripheral blood disease in breast cancer patients predicts for resistance to adjuvant chemotherapy and early relapse.
International journal of cancer. Journal international du cancer 2004;108(4):620-7.
2004: George P Stathopoulos; Konstantinos Syrigos; Aristidis Polyzos; G Fountzilas; Sotiris K Rigatos; Nikolaos Ziras; A Potamiannou; I Tsiakopoulos; Nikolaos Androulakis; Gerasimos Aravantinos; Athanasios Athanasiadis; Pavlos Papakotoulas; Vassilis Georgoulias
Front-line treatment of inoperable or metastatic pancreatic cancer with gemcitabine and capecitabine: an intergroup, multicenter, phase II study.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2004;15(2):224-9.
2004: George Fountzilas; George P Stathopoulos; George Kouvatseas; A Polychronis; George Klouvas; Epaminondas Samantas; Nikolaos Zamboglou; K Kyriakou; Adamos Adamou; D Pectasidis; Th Ekonomopoulos; Haralabos P Kalofonos; Dimitrios Bafaloukos; Vassilis Georgoulias; Evangelia Razis; Dimitrios Koukouras; V Zombolas; Paris A Kosmidis; Dimosthenis Skarlos; Nicholas Pavlidis
Adjuvant cytotoxic and endocrine therapy in pre- and postmenopausal patients with breast cancer and one to nine infiltrated nodes: five-year results of the Hellenic Cooperative Oncology Group randomized HE 10/92 study.
American journal of clinical oncology 2004;27(1):57-67.
2004: Dimitris Mavroudis; Nikolaos Malamos; Aristidis Polyzos; Ch Kouroussis; Ch Christophilakis; I Varthalitis; Nikolaos Androulakis; Kostas Kalbakis; Georgia Milaki; Vassilis Georgoulias
Front-line chemotherapy with docetaxel and gemcitabine administered every two weeks in patients with metastatic breast cancer: a multicenter phase II study.
Oncology 2004;67(3-4):250-6.
2004: Sofia Agelaki; Konstantinos Syrigos; Charalambos Christophylakis; John Boukovinas; John Varthalitis; Georgia Pavlakou; Athanasios Athanasiadis; Charalambos Kouroussis; Nikolaos Vardakis; Georgios Maltezakis; Georgia Milaki; Vassilis Georgoulias
A multicenter phase II study of the combination of irinotecan and gemcitabine in previously treated patients with small-cell lung cancer.
Oncology 2004;66(3):192-6.
2004: Stylianos Kakolyris; John Souglakos; Charalambos Kouroussis; Nikolaos Androulakis; George Samonis; Nikolaos Vardakis; Kyriakos Amarantidis; Sofia Agelaki; Dimitris Mavroudis; Nikos Xenidis; Vassilis Georgoulias
Dose escalation study on oxaliplatin and capecitabine (Xeloda) in patients with advanced solid tumors.
Oncology 2004;66(4):253-9.
2003: George Samonis; Sofia Maraki; Charalambos Kouroussis; Dimitris Mavroudis; Vassilis Georgoulias
Salmonella enterica pneumonia in a patient with lung cancer.
Journal of clinical microbiology 2003;41(12):5820-2.
2003: Katerina Angelopoulou; Tonia Spiropoulou; Aliki Stathopoulou; Dimitris Dimitroulopoulos; Nikolaos Malamos; Vassilis Georgoulias; Emmanuel Paraskevas; Evi S Lianidou
Development of a highly sensitive RT-PCR luminometric hybridization assay for human telomerase reverse-transcriptase beta-plus transcript.
Anticancer research 2003;23(6C):4821-9.
2003: Aliki Stathopoulou; Anna Gizi; Maria Perraki; Stella Apostolaki; Nikolaos Malamos; Dimitris Mavroudis; Vassilis Georgoulias; Evi S Lianidou
Real-time quantification of CK-19 mRNA-positive cells in peripheral blood of breast cancer patients using the lightcycler system.
Clinical cancer research : an official journal of the American Association for Cancer Research 2003;9(14):5145-51.
2003: John Souglakos; Nikolaos Androulakis; Dimitris Mavroudis; Charalabos Kourousis; Stylianos Kakolyris; Nikolaos Vardakis; Kostas Kalbakis; Athanasios G Pallis; Alexandros Ardavanis; Charalabos Varveris; Vassilis Georgoulias
Multicenter dose-finding study of concurrent capecitabine and radiotherapy as adjuvant treatment for operable rectal cancer.
International journal of radiation oncology, biology, physics 2003;56(5):1284-7.
2003: George Fountzilas; Evangelia Razis; Dimitrios Tsavdaridis; Maria Karina; Stefanos Labropoulos; Christos Christodoulou; Dimitrios Mavroudis; Helen Gogas; Vassilis Georgoulias; Dimosthenis Skarlos
Continuation of trastuzumab beyond disease progression is feasible and safe in patients with metastatic breast cancer: a retrospective analysis of 80 cases by the hellenic cooperative oncology group.
Clinical breast cancer 2003;4(2):120-5.
2003: Nikos Xenidis; Ioannis G Vlachonikolis; Dimitris Mavroudis; Maria Perraki; Aliki Stathopoulou; Nikolaos Malamos; Charalambos Kouroussis; Stylianos Kakolyris; Stella Apostolaki; Nikolaos Vardakis; Evi S Lianidou; Vassilis Georgoulias
Peripheral blood circulating cytokeratin-19 mRNA-positive cells after the completion of adjuvant chemotherapy in patients with operable breast cancer.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2003;14(6):849-55.
2003: Athanasios G Pallis; Dimitris Mavroudis; Nikolaos Androulakis; John Souglakos; Charalambos Kouroussis; Vassiliki Bozionelou; I G Vlachonikolis; Vassilis Georgoulias
ZD1839, a novel, oral epidermal growth factor receptor-tyrosine kinase inhibitor, as salvage treatment in patients with advanced non-small cell lung cancer. Experience from a single center participating in a compassionate use program.
Lung cancer (Amsterdam, Netherlands) 2003;40(3):301-7.
2003: Vassilis Georgoulias; Athanasios G Pallis; Charalabos Kourousis; Athanasios Alexopoulos; Alexandros Ardavanis; Athina Agelidou; Maria Agelidou; Michael Toumbis; S Tzannes; Georgia Pavlakou; Panagiotis Ziotopoulos; E Tzelepatiotis; Nikolaos Samaras
Docetaxel versus docetaxel/cisplatin in patients with advanced non-small-cell lung cancer: preliminary analysis of a multicenter, randomized phase III study.
Clinical lung cancer 2003;4(5):288-93.
2003: Aliki Stathopoulou; Dimitris Mavroudis; Maria Perraki; Stella Apostolaki; Ioannis G Vlachonikolis; Evi S Lianidou; Vassilis Georgoulias
Molecular detection of cancer cells in the peripheral blood of patients with breast cancer: comparison of CK-19, CEA and maspin as detection markers.
Anticancer research 2003;23(2C):1883-90.
2003: George P Stathopoulos; Sotiris K Rigatos; M A Dimopoulos; THEODORE GIANNAKAKIS; G Foutzilas; Charalambos Kouroussis; D Janninis; Gerasimos Aravantinos; Nikolaos Androulakis; Sofia Agelaki; John G Stathopoulos; Vassilis Georgoulias
Treatment of pancreatic cancer with a combination of irinotecan (CPT-11) and gemcitabine: a multicenter phase II study by the Greek Cooperative Group for Pancreatic Cancer.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2003;14(3):388-94.
2003: Dimitris Mavroudis; Periklis Pappas; Charalambos Kouroussis; Stylianos Kakolyris; Sofia Agelaki; Kostas Kalbakis; Nikolaos Androulakis; John Souglakos; Nikolaos Vardakis; Martha Nikolaidou; George Samonis; Marios Marselos; Vassilis Georgoulias
A dose-escalation and pharmacokinetic study of gemcitabine and oxaliplatin in patients with advanced solid tumors.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2003;14(2):304-12.
2003: Sofia Agelaki; E Karyda; Ch Kouroussis; Alexandros Ardavanis; Kostas Kalbakis; Konstantinos Malas; Nikolaos Malamos; Athanasios Alexopoulos; Evangelos Tselepatiotis; Vassilis Georgoulias
Gemcitabine plus irinotecan in breast cancer patients pretreated with taxanes and anthracyclines: a multicenter phase II study.
Oncology 2003;64(4):477-8.
2003: Dimitris Mavroudis; Athanasios Alexopoulos; Nikolaos Malamos; Alexandros Ardavanis; C Kandylis; E Stavrinidis; Ch Kouroussis; Sofia Agelaki; Nikolaos Androulakis; Vassiliki Bozionelou; Vassilis Georgoulias
Salvage treatment of metastatic breast cancer with docetaxel and carboplatin. A multicenter phase II trial.
Oncology 2003;64(3):207-12.
2003: Charalambos Kouroussis; Sofia Agelaki; Dimitris Mavroudis; Stylianos Kakolyris; Nikolaos Androulakis; Kostas Kalbakis; John Souglakos; Kostas Mallas; Vassiliki Bozionelou; Athanasios G Pallis; Helen Adamtziki; Vassilis Georgoulias
A dose escalation study of docetaxel and oxaliplatin combination in patients with metastatic breast and non-small cell lung cancer.
Anticancer research 2003;23(1B):785-91.
2003: Dimitris Mavroudis; Georgia Pavlakou; G Blazoyiannakis; Marinos Veslemes; F Apostolopoulou; Ch Kouroussis; Stylianos Kakolyris; Sofia Agelaki; Nikolaos Androulakis; Nikolaos Vardakis; EG Magkanas; George Samonis; Vassilis Georgoulias
Sequential administration of cisplatin-etoposide followed by topotecan in patients with extensive stage small cell lung cancer. A multicenter phase II study.
Lung cancer (Amsterdam, Netherlands) 2003;39(1):71-6.
2002: Charalambos Kouroussis; John Souglakos; Dimitris Mavroudis; Savvakis Papadouris; Stylianos Kakolyris; Sofia Agelaki; Kostas Kalbakis; Christos Panopoulos; Nikolaos Vardakis; Evanthia Sarra; Vassilis Georgoulias
Oxaliplatin with high-dose leucovorin and infusional 5-fluorouracil in irinotecan-pretreated patients with advanced colorectal cancer (ACC).
American journal of clinical oncology 2002;25(6):627-31.
2002: THEODORE GIANNAKAKIS; Stylianos Kakolyris; Elias Theodoropoulos; Charalambos Kouroussis; Emmanuel Michailakis; Savvakis Papadouris; Miranda Tsitoura; Kostas Kalbakis; John Souglakos; Sofia Agelaki; Nikolaos Vardakis; Vassilis Georgoulias
A multicenter phase II study of docetaxel and carboplatin combination as front-line treatment in advanced non-small cell lung cancer.
Anticancer research 2002;22(6B):3743-8.
2002: Nikolaos Androulakis; Charalambos Kouroussis; Dimitris Mavroudis; Stylianos Kakolyris; John Souglakos; Sofia Agelaki; Kostas Kalbakis; Konstantinos Malas; Athanasios G Pallis; George Samonis; Vassilis Georgoulias
Phase I study of weekly paclitaxel and liposomal doxorubicin in patients with advanced solid tumours.
European journal of cancer (Oxford, England : 1990) 2002;38(15):1992-7.
2002: Dimitris Mavroudis; Marinos Veslemes; Ch Kouroussis; Nikolaos Tzanakis; E Ferdoutsis; Michael Toumbis; Panagiotis Ziotopoulos; Maria Agelidou; Evangelos Tselepatiotis; Kostas Kalbakis; John Souglakos; EG Magkanas; George Samonis; Vassilis Georgoulias
Cisplatin-etoposide alternating with topotecan in patients with extensive stage small cell lung cancer (SCLC). A multicenter phase II study.
Lung cancer (Amsterdam, Netherlands) 2002;38(1):59-63.
2002: John Souglakos; Athanasios Kotsakis; Charalambos Kouroussis; Stylianos Kakolyris; Dimitris Mavroudis; Kostas Kalbakis; Sofia Agelaki; John Vlachonikolis; Vassilis Georgoulias; George Samonis
Nonneutropenic febrile episodes associated with docetaxel-based chemotherapy in patients with solid tumors.
Cancer 2002;95(6):1326-33.
2002: Aliki Stathopoulou; Ioannis G Vlachonikolis; Dimitris Mavroudis; Maria Perraki; Ch Kouroussis; Stella Apostolaki; Nikolaos Malamos; Stylianos Kakolyris; Athanasios Kotsakis; Nikos Xenidis; D Reppa; Vassilis Georgoulias
Molecular detection of cytokeratin-19-positive cells in the peripheral blood of patients with operable breast cancer: evaluation of their prognostic significance.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2002;20(16):3404-12.
2002: John Souglakos; Dimitris Mavroudis; Stylianos Kakolyris; Ch Kourousis; Nikolaos Vardakis; Nikolaos Androulakis; Sofia Agelaki; Kostas Kalbakis; D Tsetis; N Athanasiadis; George Samonis; Vassilis Georgoulias
Triplet combination with irinotecan plus oxaliplatin plus continuous-infusion fluorouracil and leucovorin as first-line treatment in metastatic colorectal cancer: a multicenter phase II trial.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2002;20(11):2651-7.
2002: Stylianos Souglakos John Kakolyris; Charalambos Kouroussis; Michael Koukourakis; Kostas Kalbakis; Dimitris Mavroudis; Nikolaos Vardakis; Vassilis Georgoulias
A dose-escalation study of irinotecan (CPT-11) in combination with gemcitabine in patients with advanced non-small cell lung cancer previously treated with a cisplatin-based front line chemotherapy.
Anticancer research 2002;22(3):1891-6.
2002: Vassilis Georgoulias
Docetaxel (taxotere) in the treatment of non-small cell lung cancer.
Current medicinal chemistry 2002;9(8):869-77.
2002: Lambros Vamvakas; Stylianos Kakolyris; Charalambos Kouroussis; K Kandilis; Dimitris Mavroudis; Nikolaos Ziras; Nikolaos Androulakis; Kostas Kalbakis; Evanthia Sarra; John Souglakos; Vassilis Georgoulias
Irinotecan (CPT-11) in combination with infusional 5-fluorouracil and leucovorin (de Gramont regimen) as first-line treatment in patients with advanced colorectal cancer: a multicenter phase II study.
American journal of clinical oncology 2002;25(1):65-70.
2002: Stylianos Kakolyris; Charalambos Kouroussis; Michael I Koukourakis; Dimitris Mavroudis; D Marvroudis; Konstantinos Malas; Nikolaos Vardakis; Vassiliki Bozionelou; Kostas Kalbakis; Vassilis Georgoulias
A dose-escalation study of oxaliplatin and vinorelbine in patients with advanced solid tumors.
Oncology 2002;63(3):213-8.
2002: Dimitris Mavroudis; Ch Kouroussis; Stylianos Kakolyris; Sofia Agelaki; Kostas Kalbakis; Nikolaos Androulakis; John Souglakos; George Samonis; Vassilis Georgoulias
Phase I study of paclitaxel (taxol) and pegylated liposomal doxorubicin (caelyx) administered every 2 weeks in patients with advanced solid tumors.
Oncology 2002;62(3):216-22.
2002: Christos Kosmas; Sofia Agelaki; THEODORE GIANNAKAKIS; Dimitris Mavroudis; Ch Kouroussis; Kostas Kalbakis; Savvakis Papadouris; John Souglakos; Nikolaos Malamos; Vassilis Georgoulias
Phase I study of vinorelbine and carboplatin combination in patients with taxane and anthracycline pretreated advanced breast cancer.
Oncology 2002;62(2):103-9.
2002: Michael I Koukourakis; Alexandra Giatromanolaki; Charalambos Kouroussis; Stylianos Kakolyris; Efthimios Sivridis; Chryssi Frangiadaki; George Retalis; Vassilis Georgoulias
Hypofractionated and accelerated radiotherapy with cytoprotection (HypoARC): a short, safe, and effective postoperative regimen for high-risk breast cancer patients.
International journal of radiation oncology, biology, physics 2002;52(1):144-55.
2001: Sofia Agelaki; H Bania; Charalambos Kouroussis; G Blazoyiannakis; John Souglakos; Xanthi Tsiafaki; Kostas Kalbakis; Ageliki Rapti; Nikolaos Androulakis; Vassilis Georgoulias; Emmanuel Papadakis
Second-line treatment with vinorelbine and carboplatin in patients with advanced non-small cell lung cancer. A multicenter phase II study.
Lung cancer (Amsterdam, Netherlands) 2001;34 Suppl 4():S77-80.
2001: Stylianos Kakolyris; Charalambos Kouroussis; John Souglakos; Sofia Agelaki; Kostas Kalbakis; Nikolaos Vardakis; Lambros Vamvakas; Vassilis Georgoulias
Cisplatin and irinotecan (CPT-11) as second-line treatment in patients with advanced non-small cell lung cancer.
Lung cancer (Amsterdam, Netherlands) 2001;34 Suppl 4():S71-6.
2001: Vassilis Georgoulias; George Samonis; Emmanuel Papadakis; Athanasios Alexopoulos; Xanthi Tsiafaki; Ageliki Rapti; Marinos Veslemes; T Grigoratou; P Palamidas; Charalambos Kouroussis; Dimitris Mavroudis; Stylianos Kakolyris; THEODORE GIANNAKAKIS; John Vlachonikolis
Comparison of docetaxel/cisplatin to docetaxel/gemcitabine as first-line treatment of advanced non-small cell lung cancer: early results of a randomized trial.
Lung cancer (Amsterdam, Netherlands) 2001;34 Suppl 4():S47-51.
2001: Stylianos Kakolyris; Alexandra Giatromanolaki; Michael I Koukourakis; LG Kaklamanis; Charalambos Kouroussis; Vassiliki Bozionelou; Vassilis Georgoulias; Kevin C Gatter; Adrian L Harris
Assessment of vascular maturation in lung and breast carcinomas using a novel basement membrane component, LH39.
Anticancer research 2001;21(6B):4311-6.
2001: Aliki Stathopoulou; Katerina Angelopoulou; Maria Perraki; Vassilis Georgoulias; Nikolaos Malamos; Evi S Lianidou
Quantitative RT-PCR luminometric hybridization assay with an RNA internal standard for cytokeratin-19 mRNA in peripheral blood of patients with breast cancer.
Clinical biochemistry 2001;34(8):651-9.
2001: S Kakolyris; A Giatromanolaki; M Koukourakis; Garth Powis; John Souglakos; E Sivridis; Vassilis Georgoulias; K C Gatter; A L Harris
Thioredoxin expression is associated with lymph node status and prognosis in early operable non-small cell lung cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2001;7(10):3087-91.
2001: Pavlos Papakostas; Charalambos Kouroussis; Nikolaos Androulakis; Georgios Fotios Samelis; Gerasimos Aravantinos; Kostas Kalbakis; Evanthia Sarra; John Souglakos; Stylianos Kakolyris; Vassilis Georgoulias
First-line chemotherapy with docetaxel for unresectable or metastatic carcinoma of the biliary tract. A multicentre phase II study.
European journal of cancer (Oxford, England : 1990) 2001;37(15):1833-8.
2001: Sofia Agelaki; Stylianos Kakolyris; P Palamidas; Charalambos Kouroussis; Dimitris Mavroudis; Kostas Kalbakis; Vassilis Georgoulias; A Raptis
A dose escalation study of topotecan in combination with epirubicin in pretreated patients with small-cell lung cancer.
Lung cancer (Amsterdam, Netherlands) 2001;34(1):133-9.
2001: Kostas Kalbakis; Charalambos Kouroussis; Stylianos Kakolyris; Dimitris Mavroudis; John Souglakos; Sofia Agelaki; Lambros Vamvakas; M Christodoulakis; K Stylianou; Vassilis Georgoulias
Salvage chemotherapy with high-dose leucovorin (LV) and 48-hour continuous infusion (CI) of 5-fluorouracil (5-FU) in combination with conventional doses of cyclophosphamide (CPM) in patients with metastatic breast cancer (MBC) pretreated with anthracycline and taxanes.
British journal of cancer 2001;85(6):798-802.
2001: Charalambos Kouroussis; Stylianos Kakolyris; Dimitris Mavroudis; Nikolaos Androulakis; Kostas Kalbakis; Sofia Agelaki; Evanthia Sarra; John Souglakos; M Christodoulakis; George Samonis; Vassilis Georgoulias
A dose-finding study of the weekly administration of paclitaxel in patients with advanced solid tumors.
American journal of clinical oncology 2001;24(4):404-7.
2001: Athanasios Alexopoulos; Charalambos Kouroussis; Nikolaos Malamos; Stylianos Kakolyris; Kostas Kalbakis; Christos Kosmas; Dimitris Mavroudis; Sofia Agelaki; J Vlachonicolis; Evanthia Sarra; Gerasimos Rigatos; Vassilis Georgoulias
Docetaxel in combination with mitoxantrone and granulocyte colony-stimulating factor as front-line chemotherapy in metastatic breast cancer: a multicenter phase II study.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2001;12(6):793-8.
2001: J Janinis; M Papadakou; G Panagos; A Panousaki; Vassilis Georgoulias; Dora Hatzidaki; Dimitris Lefantzis; George Dokianakis
Sequential chemoradiotherapy with docetaxel, cisplatin, and 5-fluorouracil in patients with locally advanced head and neck cancer.
American journal of clinical oncology 2001;24(3):227-31.
2001: Vassilis Georgoulias; Emmanuel Papadakis; Athanasios Alexopoulos; Xanthi Tsiafaki; Ageliki Rapti; Marinos Veslemes; P Palamidas; I Vlachonikolis
Platinum-based and non-platinum-based chemotherapy in advanced non-small-cell lung cancer: a randomised multicentre trial.
Lancet 2001;357(9267):1478-84.
2001: George Samonis; Maria Anatoliotaki; H Apostolakou; Sofia Maraki; D Mavroudis; Vassilis Georgoulias
Transient fungemia due to Rhodotorula rubra in a cancer patient: case report and review of the literature.
Infection 2001;29(3):173-6.
2001: Stylianos Kakolyris; Emmanuel Papadakis; Xanthi Tsiafaki; C Kalofonos; Ageliki Rapti; Michael Toubis; E Bania; Charalambos Kouroussis; K Chainis; Nikolaos Androulakis; Sofia Agelaki; Evanthia Sarra; Nikolaos Vardakis; Vassilis Georgoulias
Docetaxel in combination with gemcitabine plus rhG-CSF support as second-line treatment in non-small cell lung cancer. A multicenter phase II study.
Lung cancer (Amsterdam, Netherlands) 2001;32(2):179-87.
2001: Michael I Koukourakis; Alexandra Giatromanolaki; Stylianos Kakolyris; E Sivridis; Vassilis Georgoulias; G Funtzilas; I D Hickson; Kevin C Gatter; Adrian L Harris
Nuclear expression of human apurinic/apyrimidinic endonuclease (HAP1/Ref-1) in head-and-neck cancer is associated with resistance to chemoradiotherapy and poor outcome.
International journal of radiation oncology, biology, physics 2001;50(1):27-36.
2001: Dimitris Mavroudis; Emmanuel Papadakis; Marinos Veslemes; Xanthi Tsiafaki; J Stavrakakis; Charalambos Kouroussis; Stylianos Kakolyris; E Bania; JB Jordanoglou; Maria Agelidou; J Vlachonicolis; Vassilis Georgoulias
A multicenter randomized clinical trial comparing paclitaxel-cisplatin-etoposide versus cisplatin-etoposide as first-line treatment in patients with small-cell lung cancer.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2001;12(4):463-70.
2001: S Kakolyris; D Mavroudis; N Tsavaris; John Souglakos; P Tsiafaki; Kostas Kalbakis; Sofia Agelaki; Nikolaos Androulakis; Vassilis Georgoulias
Paclitaxel in combination with carboplatin as salvage treatment in refractory small-cell lung cancer (SCLC): a multicenter phase II study.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2001;12(2):193-7.
2001: Vassilis Georgoulias
Docetaxel/gemcitabine: salvage chemotherapy in anthracycline-pretreated patients with advanced breast cancer.
Oncology (Williston Park, N.Y.) 2001;15(2 Suppl 3):18-24.
2001: S Kakolyris; Charalambos Kouroussis; John Souglakos; D Mavroudis; Sofia Agelaki; Kostas Kalbakis; Nikolaos Androulakis; Nikolaos Vardakis; Lambros Vamvakas; Vassilis Georgoulias
A phase I clinical trial of topotecan given every 2 weeks in patients with refractory solid tumors.
Oncology 2001;61(4):265-70.
2001: George Samonis; Maria Anatoliotaki; H Apostolakou; J Souglakos; Vassilis Georgoulias
Fatal septicemia and meningitis due to Morganella morganii in a patient with Hodgkin's disease.
Scandinavian journal of infectious diseases 2001;33(7):553-5.
2001: Charalambos Kouroussis; John Souglakos; Stylianos Kakolyris; Dimitris Mavroudis; Nikolaos Malamos; Kostas Kalbakis; Nikolaos Androulakis; A Agelaki; Nikolaos Vardakis; George Samonis; Vassilis Georgoulias
Oxaliplatin in combination with infusional 5-fluorouracil and leucovorin every 2 weeks as first-line treatment in patients with advanced colorectal cancer: a phase II study.
Oncology 2001;61(1):36-41.
2001: Sofia Agelaki; H Bania; Charalambos Kouroussis; G Blazoyiannakis; John Souglakos; Xanthi Tsiafaki; A Harpidou; Kostas Kalbakis; Ageliki Rapti; Nikolaos Androulakis; Evanthia Sarra; Vassilis Georgoulias; Emmanuel Papadakis
Vinorelbine-based regimens as salvage treatment in patients with advanced non-small cell lung cancer: two parallel multicenter phase II trials.
Oncology 2001;60(3):235-41.
2001: Stylianos Kakolyris; John Souglakos; Charalambos Kouroussis; Nikolaos Androulakis; Dimitris Mavroudis; Kostas Kalbakis; Athanasios Kotsakis; Nikolaos Vardakis; Michael I Koukourakis; J Romanos; Vassilis Georgoulias
A dose-finding study of irinotecan (CPT-11) plus a four-day continuous 5-fluorouracil infusion in advanced colorectal cancer.
Oncology 2001;60(3):207-13.
2001: George P Stathopoulos; Dimitris Mavroudis; Nicolas Tsavaris; Charalambos Kouroussis; Gerasimos Aravantinos; Sofia Agelaki; Stylianos Kakolyris; Sotiris K Rigatos; Spyros Karabekios; Vassilis Georgoulias
Treatment of pancreatic cancer with a combination of docetaxel, gemcitabine and granulocyte colony-stimulating factor: a phase II study of the Greek Cooperative Group for Pancreatic Cancer.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2001;12(1):101-3.
2000: Stylianos Kakolyris; John Souglakos; Sofia Agelaki; Charalabos Kourousis; Dimitris Mavroudis; Evanthia Sarra; P Malliotakis; Vassilis Georgoulias
A dose-escalation study of irinotecan (CPT-11) in combination with cisplatin in patients with advanced non-small cell lung cancer previously treated with a docetaxel-based front line chemotherapy.
Lung cancer (Amsterdam, Netherlands) 2000;30(3):193-8.
2000: Dimitris Mavroudis; Athanasios Alexopoulos; Nikolaos Ziras; Nikolaos Malamos; Charalambos Kouroussis; Stylianos Kakolyris; Sofia Agelaki; Kostas Kalbakis; Nicolas Tsavaris; Anna Potamianou; Gerasimos Rigatos; Vassilis Georgoulias
Front-line treatment of advanced breast cancer with docetaxel and epirubicin: a multicenter phase II study.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2000;11(10):1249-54.
2000: Athanasios Kotsakis; Evanthia Sarra; M Peraki; Michael I Koukourakis; Stella Apostolaki; John Souglakos; E Mavromanomakis; John Vlachonikolis; Vassilis Georgoulias
Docetaxel-induced lymphopenia in patients with solid tumors: a prospective phenotypic analysis.
Cancer 2000;89(6):1380-6.
2000: S Kakolyris; Vassilis Georgoulias
The role of gemcitabine and paclitaxel as second-line chemotherapy for the treatment of advanced non small-cell lung cancer (NSCLC).
Clinical lung cancer 2000;2(1):43-7.
2000: Dimitris Mavroudis; Charalabos Kourousis; Nikolaos Androulakis; Kostas Kalbakis; Sofia Agelaki; Stylianos Kakolyris; John Souglakos; Evanthia Sarra; Nikolaos Vardakis; Dora Hatzidaki; G Sarmonis; Vassilis Georgoulias
Frontline treatment of advanced gastric cancer with docetaxel and granulocyte colony-stimulating factor (G-CSF): a phase II trial.
American journal of clinical oncology 2000;23(4):341-4.
2000: Meletios A Dimopoulos; Christos A Papadimitriou; Vassilis Georgoulias; Lia A Moulopoulos; Gerasimos Aravantinos; Dimitra Gika; S Karpathios; Stamatios F Stamatelopoulos
Paclitaxel and cisplatin in advanced or recurrent carcinoma of the endometrium: long-term results of a phase II multicenter study.
Gynecologic oncology 2000;78(1):52-7.
2000: Stylianos Kakolyris; Charalambos Kouroussis; Kostas Kalbakis; Dimitris Mavroudis; John Souglakos; S Kremos; Vassilis Georgoulias
Salvage treatment of advanced non-small-cell lung cancer previously treated with docetaxel-based front-line chemotherapy with irinotecan (CPT-11) in combination with cisplatin.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2000;11(6):757-60.
2000: Charalambos Kouroussis; George Samonis; Nikolaos Androulakis; John Souglakos; Argyro Voloudaki; Meletios A Dimopoulos; T Kotsakis; Stylianos Kakolyris; Kostas Kalbakis; Vassilis Georgoulias
Successful conservative treatment of neutropenic enterocolitis complicating taxane-based chemotherapy: a report of five cases.
American journal of clinical oncology 2000;23(3):309-13.
2000: Michael I Koukourakis; G Kyrias; Stylianos Kakolyris; Charalambos Kouroussis; C Frangiadaki; Alexandra Giatromanolaki; George Retalis; Vassilis Georgoulias
Subcutaneous administration of amifostine during fractionated radiotherapy: a randomized phase II study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2000;18(11):2226-33.
2000: Michael I Koukourakis; Alexandra Giatromanolaki; Stylianos Kakolyris; Marios E Froudarakis; Vassilis Georgoulias; George Retalis; N Bahlitzanakis
Phase I/II dose escalation study of docetaxel and carboplatin combination supported with amifostine and GM-CSF in patients with incomplete response following docetaxel chemo-radiotherapy: additional chemotherapy enhances regression of residual cancer.
Medical oncology (Northwood, London, England) 2000;17(2):135-43.
2000: Panagiotis Kanavaros; Kalliopi Stefanaki; John Vlachonikolis; G Eliopoulos; Stylianos Kakolyris; DEMETRA RONTOGIANNI; V Gorgoulis; Vassilis Georgoulias
Expression of p53, p21/waf1, bcl-2, bax, Rb and Ki67 proteins in Hodgkin's lymphomas.
Histology and histopathology 2000;15(2):445-53.
2000: THEODORE GIANNAKAKIS; Nikolaos Ziras; Stylianos Kakolyris; Dimitris Mavroudis; Nikolaos Androulakis; Sofia Agelaki; M Parashos; Evanthia Sarra; T Dimou; Dora Hatzidaki; John Vlachonikolis; Vassilis Georgoulias
Docetaxel in combination with carboplatin for the treatment of advanced non-small cell lung carcinoma: a multicentre phase I study.
European journal of cancer (Oxford, England : 1990) 2000;36(6):742-7.
2000: Dimitris Mavroudis; Charalabos Kourousis; Stylianos Kakolyris; Sofia Agelaki; Kostas Kalbakis; Nikolaos Androulakis; John Souglakos; Nikolaos Vardakis; George Samonis; Vassilis Georgoulias
Phase I study of the gemcitabine/oxaliplatin combination in patients with advanced solid tumors: a preliminary report.
Seminars in oncology 2000;27(1 Suppl 2):25-30.
2000: Stylianos Kakolyris; LG Kaklamanis; M J Koukourakis; Alexandra Giatromanolaki; M Rousomoustakaki; J C Souglakos; D K Reppa; Vassilis Georgoulias; Kevin C Gatter; Adrian L Harris
Angiogenesis and p53 expression in the colorectal adenoma-carcinoma sequence.
Oncology research 2000;12(4):203-8.
2000: Charalambos Kouroussis; Sofia Agelaki; Dimitris Mavroudis; John Souglakos; Stylianos Kakolyris; Kostas Kalbakis; Nikolaos Vardakis; D Reppa; Dora Hatzidaki; George Samonis; Vassilis Georgoulias
A dose escalation study of weekly docetaxel in patients with advanced solid tumors.
Cancer chemotherapy and pharmacology 2000;46(6):488-92.
1999: Stylianos Kakolyris; Charalabos Kourousis; Michael I Koukourakis; Nikolaos Androulakis; Lambros Vamvakas; Sofia Agelaki; Dora Hatzidaki; George Samonis; Dimitris D Tsiftsis; Vassilis Georgoulias
First-line treatment of metastatic breast cancer with mitoxantrone, vinorelbine, and carboplatin.
American journal of clinical oncology 1999;22(6):568-72.
1999: Meletios A Dimopoulos; Chris N Bakoyannis; Vassilis Georgoulias; Christos Papadimitriou; Lia A Moulopoulos; Charalambos Deliveliotis; A Karayannis; Ioannis M Varkarakis; Gerasimos Aravantinos; Anastasios Zervas; Dimitrios Pantazopoulos; George Fountzilas; Aristotelis Bamias; Zacharias Kyriakakis; Athanasios Anagnostopoulos; Aris Giannopoulos; Paris A Kosmidis
Docetaxel and cisplatin combination chemotherapy in advanced carcinoma of the urothelium: a multicenter phase II study of the Hellenic Cooperative Oncology Group.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1999;10(11):1385-8.
1999: Vassilis Georgoulias; J P Crown
Increasing options in cancer therapy: current status and future prospects.
Anti-cancer drugs 1999;10 Suppl 1():S1-3.
1999: Charalambos Kouroussis; Vassilis Georgoulias; John Souglakos; E Simvoulakis; Spyros Karabekios; George Samonis
Spontaneous spondylodiscitis caused by Klebsiella pneumoniae.
Infection 1999;27(6):368-9.
1999: Stylianos Kakolyris; Alexandra Giatromanolaki; Michael I Koukourakis; LG Kaklamanis; P Kanavaros; Ian D Hickson; G Barzilay; Vassilis Georgoulias; Kevin C Gatter; Adrian L Harris
Nuclear localization of human AP endonuclease 1 (HAP1/Ref-1) associates with prognosis in early operable non-small cell lung cancer (NSCLC).
The Journal of pathology 1999;189(3):351-7.
1999: Alexandra Giatromanolaki; George P Stathopoulos; E Tsiompanou; E Tsiobanou; C Papadimitriou; Vassilis Georgoulias; K C Gatter; A L Harris; Michael I Koukourakis
Combined role of tumor angiogenesis, bcl-2, and p53 expression in the prognosis of patients with colorectal carcinoma.
Cancer 1999;86(8):1421-30.
1999: Panayiotis A Theodoropoulos; Hara Polioudaki; O Kostaki; S P Derdas; Vassilis Georgoulias; C Dargemont; Spyros D Georgatos
Taxol affects nuclear lamina and pore complex organization and inhibits import of karyophilic proteins into the cell nucleus.
Cancer research 1999;59(18):4625-33.
1999: Michael I Koukourakis; N Bahlitzanakis; Marios E Froudarakis; Alexandra Giatromanolaki; Vassilis Georgoulias; S Koumiotaki; M Christodoulou; G Kyrias; J Skarlatos; J Kostantelos; K Beroukas
Concurrent conventionally factionated radiotherapy and weekly docetaxel in the treatment of stage IIIb non-small-cell lung carcinoma.
British journal of cancer 1999;80(11):1792-6.
1999: Nikolaos Androulakis; Charalabos Kourousis; Meletios A Dimopoulos; Georgios Fotios Samelis; Stylianos Kakolyris; Nicolas Tsavaris; K Genatas; Gerasimos Aravantinos; Christos Papadimitriou; Spyros Karabekios; George P Stathopoulos; Vassilis Georgoulias
Treatment of pancreatic cancer with docetaxel and granulocyte colony-stimulating factor: a multicenter phase II study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1999;17(6):1779-85.
1999: Stylianos Kakolyris; George Samonis; Michael I Koukourakis; J Vlachonicolis; Kostas Kalbakis; Sofia Agelaki; george chalkiadakis; Elias Sanidas; Dimitris D Tsiftsis; Vassilis Georgoulias
First-line treatment with mitoxantrone, methotrexate, vincristine, and carboplatine (MIMOC) plus cyclical hormonotherapy with tamoxifen and megestrol acetate in advanced breast cancer.
American journal of clinical oncology 1999;22(3):273-7.
1999: Charalambos Kouroussis; E Xydakis; Anna Potamianou; THEODORE GIANNAKAKIS; Stylianos Kakolyris; Sofia Agelaki; E Sara; Nikolaos Malamos; Athanasios Alexopoulos; Dimitris Mavroudis; George Samonis; Savvakis Papadouris; Vassilis Georgoulias; G Panagos
Front-line treatment of metastatic breast cancer with docetaxel and epirubicin: a multicenter dose-escalation study. The Greek Breast Cancer Cooperative Group (GBCCG).
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1999;10(5):547-52.
1999: Panagiotis Kanavaros; Kalliopi Stefanaki; KE Valassiadou; John Vlachonikolis; M Mavromanolakis; Marianna Vlychou; Stylianos Kakolyris; V Gorgoulis; Maria Tzardi; Vassilis Georgoulias
Expression of p53, p21/waf, bcl-2, bax, Rb and Ki67 proteins in colorectal adenocarcinomas.
Medical oncology (Northwood, London, England) 1999;16(1):23-30.
1999: Panagiotis Kanavaros; Marianna Vlychou; Kalliopi Stefanaki; DEMETRA RONTOGIANNI; Philippe Gaulard; E Pantelidaki; M Zois; Katherine Darivianaki; Vassilis Georgoulias; Marie-Laure Boulland; V Gorgoulis; C Kittas
Cytotoxic protein expression in non-Hodgkin's lymphomas and Hodgkin's disease.
Anticancer research 1999;19(2A):1209-16.
1999: Vassilis Georgoulias; Charalambos Kouroussis; Nikolaos Androulakis; Stylianos Kakolyris; Meletios A Dimopoulos; Emmanuel Papadakis; Demosthenes Bouros; F Apostolopoulou; Christos Papadimitriou; Athina Agelidou; Kostas D Hatzakis; Kostas Kalbakis; Athanasios Kotsakis; Nikolaos Vardakis; J Vlachonicolis
Front-line treatment of advanced non-small-cell lung cancer with docetaxel and gemcitabine: a multicenter phase II trial.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1999;17(3):914-20.
1999: Charalambos Kouroussis; Nikolaos Androulakis; Stylianos Kakolyris; John Souglakos; T Kotsakis; Dimitris Mavroudis; K Katsogridakis; Nikolaos Vardakis; Dora Hatzidaki; George Samonis; John Vlachonikolis; Vassilis Georgoulias
Dose-escalation study of docetaxel in combination with mitoxantrone as first-line treatment in patients with metastatic breast cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1999;17(3):862-9.
1999: Dimitris Mavroudis; Nikolaos Malamos; Athanasios Alexopoulos; Charalabos Kourousis; Sofia Agelaki; Evanthia Sarra; Anna Potamianou; Christos Kosmas; Gerasimos Rigatos; THEODORE GIANNAKAKIS; Kostas Kalbakis; F Apostolaki; J Vlachonicolis; Stylianos Kakolyris; George Samonis; Vassilis Georgoulias
Salvage chemotherapy in anthracycline-pretreated metastatic breast cancer patients with docetaxel and gemcitabine: a multicenter phase II trial. Greek Breast Cancer Cooperative Group.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1999;10(2):211-5.
1999: Panagiotis Kanavaros; Kalliopi Stefanaki; DEMETRA RONTOGIANNI; Katherine Darivianaki; Marianna Vlychou; Eufrosini Papadaki; G Eliopoulos; M Bakiri; C Matsouka; Stylianos Kakolyris; Vassilis Georgoulias
Immunohistochemical detection of p53, mdm2, waf1/p21, and Ki67 proteins in bone marrow biopsies in myelodysplastic syndroms, acute myelogenous leukaemias and chronic myeloproliferative disorders.
Clinical and experimental pathology 1999;47(5):231-8.
1999: Alexandra Giatromanolaki; E Sivridis; M I Koukourakis; Vassilis Georgoulias; Kevin C Gatter; Adrian L Harris
Intratumoral angiogenesis: a new prognostic indicator for stage I endometrial adenocarcinomas?
Oncology research 1999;11(4):205-12.
1999: E Sara; Athanasios Kotsakis; J Souklakos; Charalabos Kourousis; Stylianos Kakolyris; E Mavromanolakis; J Vlachonicolis; Vassilis Georgoulias
Post-chemotherapy lymphopoiesis in patients with solid tumors is characterized by CD4+ cell proliferation.
Anticancer research 1999;19(1A):471-6.
1999: Michael I Koukourakis; Alexandra Giatromanolaki; S Schiza; Stylianos Kakolyris; Vassilis Georgoulias
Concurrent twice-a-week docetaxel and radiotherapy: a dose escalation trial with immunological toxicity evaluation.
International journal of radiation oncology, biology, physics 1999;43(1):107-14.
1999: K Alexopoulos; Charalambos Kouroussis; Nikolaos Androulakis; Emmanuel Papadakis; M Vaslamatzis; Stylianos Kakolyris; Georgios Fotios Samelis; E Patila; Andreas Vossos; Epaminondas Samantas; Vassilis Georgoulias
Docetaxel and granulocyte colony-stimulating factor in patients with advanced non-small-cell lung cancer previously treated with platinum-based chemotherapy: a multicenter phase II trial.
Cancer chemotherapy and pharmacology 1999;43(3):257-62.
1998: Stylianos Kakolyris; LG Kaklamanis; Alexandra Giatromanolaki; Michael I Koukourakis; Ian D Hickson; G Barzilay; Helen Turley; Russell Leek; P Kanavaros; Vassilis Georgoulias; Kevin C Gatter; Adrian L Harris
Expression and subcellular localization of human AP endonuclease 1 (HAP1/Ref-1) protein: a basis for its role in human disease.
Histopathology 1998;33(6):561-9.
1998: Alexandra Giatromanolaki; Michael I Koukourakis; S Kakolyris; Helen Turley; K O'Byrne; P A Scott; F Pezzella; Vassilis Georgoulias; Adrian L Harris; Kevin C Gatter
Vascular endothelial growth factor, wild-type p53, and angiogenesis in early operable non-small cell lung cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 1998;4(12):3017-24.
1998: Michael I Koukourakis; I Stefanaki; Alexandra Giatromanolaki; C Frangiadaki; A Armenaki; Vassilis Georgoulias; E Koumandakis; A Kranidis; E Helidonis
Fractionated carboplatin radiosensitization: a phase I dose-escalation study.
American journal of clinical oncology 1998;21(6):595-601.
1998: Charalabos Kourousis; Nikolaos Androulakis; Stylianos Kakolyris; John Souglakos; Georgios Maltezakis; G Metaxaris; george chalkiadakis; George Samonis; John Vlachonikolis; Vassilis Georgoulias
First-line treatment of advanced nonsmall cell lung carcinoma with docetaxel and vinorelbine.
Cancer 1998;83(10):2083-90.
1998: Nikolaos Androulakis; Charalambos Kouroussis; Stylianos Kakolyris; S Tzannes; Emmanuel Papadakis; Christos Papadimitriou; A Geroyianni; T Georgopoulou; I Dimopoulou; John Souglakos; Athanasios Kotsakis; Nikolaos Vardakis; Dora Hatzidaki; Vassilis Georgoulias
Salvage treatment with paclitaxel and gemcitabine for patients with non-small-cell lung cancer after cisplatin- or docetaxel-based chemotherapy: a multicenter phase II study.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1998;9(10):1127-30.
1998: Stylianos Kakolyris; George Samonis; Michael I Koukourakis; I Vlachonicolis; george chalkiadakis; Kostas Kalbakis; I Souglakos; Sofia Agelaki; P Toloudis; Vassilis Georgoulias
Treatment of non-small-cell lung cancer with prolonged oral etoposide.
American journal of clinical oncology 1998;21(5):505-8.
1998: Vassilis Georgoulias; Nikolaos Androulakis; Demosthenes Bouros; Charalambos Kouroussis; K Chatzakis; M Papadakis; F Apostopoloulou; T Georgopoulou; T Kotsakis; J Souklakos; Dora Hatzidaki; John Vlachonikolis; G Panagos
Combination chemotherapy with docetaxel, vinorelbine and cisplatin as first-line treatment of advanced non-small-cell lung cancer: a multicenter phase II study of the Greek Cooperative Group for Lung Cancer.
Lung cancer (Amsterdam, Netherlands) 1998;21(3):213-20.
1998: George Samonis; Panagiotis Skordilis; Sofia Maraki; George Datseris; P Toloudis; Ioannis Chatzinikolaou; Vassilis Georgoulias; Gerald P Bodey
Oropharyngeal candidiasis as a marker for esophageal candidiasis in patients with cancer.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 1998;27(2):283-6.
1998: Kalliopi Stefanaki; Maria Tzardi; CH Kouvidou; V Chaniotis; M Bolioti; Marianna Vlychou; M Zois; Stylianos Kakolyris; George S Delides; DEMETRA RONTOGIANNI; Vassilis Georgoulias; Panagiotis Kanavaros
Expression of p53, p21, mdm2, Rb, bax and Ki67 proteins in lymphomas of the mucosa-associated lymphoid (MALT) tissue.
Anticancer research 1998;18(4A):2403-8.
1998: Charalabos Kourousis; Stylianos Kakolyris; Nikolaos Androulakis; P Heras; J Vlachonicolis; Lambros Vamvakas; M Vlata; Dora Hatzidaki; George Samonis; Vassilis Georgoulias
Salvage chemotherapy with paclitaxel, vinorelbine, and cisplatin (PVC) in anthracycline-resistant advanced breast cancer.
American journal of clinical oncology 1998;21(3):226-32.
1998: Michael I Koukourakis; Charalabos Kourousis; M Kamilaki; S Koukouraki; Alexandra Giatromanolaki; Stylianos Kakolyris; Athanasios Kotsakis; Nikolaos Androulakis; N Bahlitzanakis; Vassilis Georgoulias
Weekly docetaxel and concomitant boost radiotherapy for non-small cell lung cancer. A phase I/II dose escalation trial.
European journal of cancer (Oxford, England : 1990) 1998;34(6):838-44.
1998: Kalliopi Stefanaki; D Rontogiannis; C Vamvouka; S Bolioti; V Chaniotis; F Sotsiou; Marianna Vlychou; G Delidis; Stylianos Kakolyris; Vassilis Georgoulias; Panagiotis Kanavaros
Immunohistochemical detection of bcl2, p53, mdm2 and p21/waf1 proteins in small-cell lung carcinomas.
Anticancer research 1998;18(3A):1689-95.
1998: Kalliopi Stefanaki; D Rontogiannis; C Vamvouka; S Bolioti; V Chaniotis; F Sotsiou; Marianna Vlychou; G Delidis; Stylianos Kakolyris; Vassilis Georgoulias; Panagiotis Kanavaros
Immunohistochemical detection of bcl2, p53, mdm2 and p21/waf1 proteins in small-cell lung carcinomas.
Anticancer research 1998;18(2A):1167-73.
1998: Vassilis Georgoulias; Nikolaos Androulakis; Athanassios Meletios Dimopoulos; Charalabos Kourousis; Stylianos Kakolyris; Emmanuel Papadakis; F Apostolopoulou; Christos Papadimitriou; Andreas Vossos; Maria Agelidou; P Heras; S Tzannes; J Vlachonicolis; E Mavromanolakis; Dora Hatzidaki
First-line treatment of advanced non-small-cell lung cancer with docetaxel and cisplatin: a multicenter phase II study.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1998;9(3):331-4.
1997: George Samonis; Dimitrios Bafaloukos; Andrew Margioris; G Katsarma; P Toloudis; C Bacoyannis; N Karvounis; Vassilis Georgoulias; Paris A Kosmidis
First-line chemotherapy of advanced breast cancer with a combination of mitoxantrone, methotrexate, and vincristine (MIMO).
Oncology 1997;54(5):371-5.
1997: Vassilis Georgoulias; Charalabos Kourousis; Nikolaos Androulakis; Stylianos Kakolyris; Meletios A Dimopoulos; Demosthenes Bouros; Christos Papadimitriou; Kostas D Hatzakis; P Heras; Kostas Kalbakis; T Kotsakis; Nikolaos Vardakis; N Meramveliotakis; Dora Hatzidaki
Docetaxel (Taxotere) and gemcitabine in the treatment of non-small cell lung cancer: preliminary results.
Seminars in oncology 1997;24(4 Suppl 14):S14-22-S14-25.
1997: Vassilis Georgoulias; Charalabos Kourousis; Nikolaos Androulakis; Stylianos Kakolyris; Emmanuel Papadakis; Demosthenes Bouros; F Apostolopoulou; T Georgopoulou; Maria Agelidou; John Souglakos; george chalkiadakis; Dora Hatzidaki
Docetaxel (Taxotere) and vinorelbine in the treatment of non-small cell lung cancer.
Seminars in oncology 1997;24(4 Suppl 14):S14-9-S14-14.
1997: Vassilis Georgoulias; Charalabos Kourousis; Stylianos Kakolyris; Nikolaos Androulakis; Meletios A Dimopoulos; Emmanuel Papadakis; T Kotsakis; Nikolaos Vardakis; Kostas Kalbakis; N Merambeliotakis; Dora Hatzidaki
Second-line treatment of advanced non-small cell lung cancer with paclitaxel and gemcitabine: a preliminary report on an active regimen.
Seminars in oncology 1997;24(4 Suppl 12):S12-61-S12-66.
1997: CH Kouvidou; Kalliopi Stefanaki; Y Dai; Maria Tzardi; Katerina Koutsoubi; Katherine Darivianaki; E Karidi; DEMETRA RONTOGIANNI; E Zois; Stylianos Kakolyris; Vassilis Georgoulias; George S Delides; Panagiotis Kanavaros
P21/waf1 protein expression in nasopharyngeal carcinoma. Comparative study with PCNA, p53 and MDM-2 protein expression.
Anticancer research 1997;17(4A):2615-9.
1997: KE Valassiadou; Kalliopi Stefanaki; Maria Tzardi; George Datseris; Vassilis Georgoulias; John Melissas; Dimitris D Tsiftsis; George S Delides; Panagiotis Kanavaros
Immunohistochemical expression of p53, bcl-2, mdm2 and waf1/p21 proteins in colorectal adenocarcinomas.
Anticancer research 1997;17(4A):2571-6.
1997: Michael I Koukourakis; Sophia Koukouraki; Alexandra Giatromanolaki; J Skarlatos; Vassilis Georgoulias; Nikolaos Karkavitsas
Non-small cell lung cancer functional imaging: increased hexakis-2-methoxy-isobutyl-isonitrile tumor clearance correlates with resistance to cytotoxic treatment.
Clinical cancer research : an official journal of the American Association for Cancer Research 1997;3(5):749-54.
1997: Elpida Giannikaki; CH Kouvidou; Maria Tzardi; Kalliopi Stefanaki; Katerina Koutsoubi; M Gregoriou; E Zois; Stylianos Kakolyris; C Mavroudi; George S Delides; Vassilis Georgoulias; Panagiotis Kanavaros
p53 protein expression in breast carcinomas. Comparative study with the wild type p53 induced proteins mdm2 and p21/waf1.
Anticancer research 1997;17(3C):2123-7.